https://annualreport.chdr.nl/overview 2026-02-05T11:22:49+01:00 https://annualreport.chdr.nl/2025 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/2025/2025-in-perspective 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/2025-in-perspective/annual-report-2025-where-innovation-meets-application 2026-02-05T10:12:39+01:00 https://annualreport.chdr.nl/2025/2025-in-perspective/investing-in-future-success 2026-02-05T09:46:33+01:00 https://annualreport.chdr.nl/2025/2025-in-perspective/2025-in-numbers 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/2025-in-perspective/2025-in-numbers/e66dd9baa3-1767706170/ar2024clinical_17_2048.jpg https://annualreport.chdr.nl/2025/bas-van-kraaij 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/titia-ruijs 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/gert-jan-hassing 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/eva-thijssen 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/ahnjili-zhuparris 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/jannik-rousel 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/eveline-in-t-veld 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/mahdi-saghari 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/wouter-ten-voorde 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/2025/developing-drugs 2026-02-03T16:55:23+01:00 https://annualreport.chdr.nl/2025/developing-drugs/neurokit-test-used-in-the-united-kingdom 2026-02-05T09:51:35+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/neurokit-test-used-in-the-united-kingdom/a7a3377772-1770132144/ar2024clinical_13.jpg https://annualreport.chdr.nl/2025/developing-drugs/reproducible-results-thanks-to-objective-measurements-dr-gerard-marek-gilgamesh-pharma 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/reproducible-results-thanks-to-objective-measurements-dr-gerard-marek-gilgamesh-pharma/bf12258d82-1770046968/generated-image.png https://annualreport.chdr.nl/2025/developing-drugs/complex-study-provided-insight-into-immunological-pathways 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/2025/developing-drugs/the-next-step-in-an-immunological-journey-of-discovery-professor-frederic-triebel-immutep 2026-02-03T16:17:19+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/the-next-step-in-an-immunological-journey-of-discovery-professor-frederic-triebel-immutep/4a7ade0b7d-1770029062/triebel.jpg https://annualreport.chdr.nl/2025/developing-drugs/favourable-results-for-ampa-pam-osavampator 2026-02-03T16:21:36+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/favourable-results-for-ampa-pam-osavampator/bfac35dbcd-1770132094/chdr-rc-253031.jpg https://annualreport.chdr.nl/2025/developing-drugs/novel-treatments-for-patients-with-atopic-dermatitis 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-treatments-for-patients-with-atopic-dermatitis/718a34f7b8-1770028629/chatgpt-image-feb-2-2026-11_36_46-am.png https://annualreport.chdr.nl/2025/developing-drugs/promising-results-from-a-novel-psychedelic-compound 2026-02-03T16:22:06+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/promising-results-from-a-novel-psychedelic-compound/44ac96df51-1770132125/ar2024clinical_02.jpg https://annualreport.chdr.nl/2025/developing-drugs/new-co2-challenge-setup-ready-for-proof-of-mechanism-studies-with-anxiolytic-drugs 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients 2026-02-03T16:15:20+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients/80df40d53c-1770028865/chatgpt-image-feb-2-2026-11_40_31-am.png https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients/7328edb453-1770131719/ra-patient.jpg https://annualreport.chdr.nl/2025/developing-drugs/successful-next-step-for-potential-treatment-of-frontotemporal-dementia 2026-02-03T16:26:04+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/successful-next-step-for-potential-treatment-of-frontotemporal-dementia/dbc02f7017-1770132362/chdr-rc-252444.jpg https://annualreport.chdr.nl/2025/developing-drugs/genotyped-cohort-facilitates-recruitment-for-studies-in-parkinson-s-disease 2026-02-05T09:35:23+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/genotyped-cohort-facilitates-recruitment-for-studies-in-parkinson-s-disease/5e2b29d4ab-1770280518/parkinson-swab-studie.jpg https://annualreport.chdr.nl/2025/developing-methods 2026-02-03T14:09:27+01:00 https://annualreport.chdr.nl/2025/developing-methods/neurokit-ready-for-clinical-studies-in-the-usa 2026-02-05T09:52:37+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/neurokit-ready-for-clinical-studies-in-the-usa/763d2e0bf5-1770133178/neurokit-usa.jpg https://annualreport.chdr.nl/2025/developing-methods/utility-function-ranks-opioids 2026-02-03T16:40:14+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/utility-function-ranks-opioids/94b1fec884-1770133213/chdr-rc-252569.jpg https://annualreport.chdr.nl/2025/developing-methods/in-depth-insight-into-immunological-challenge-models-allows-for-tailor-made-approach 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/in-depth-insight-into-immunological-challenge-models-allows-for-tailor-made-approach/9917e24c6a-1770029497/chdr-rc-252103.jpg https://annualreport.chdr.nl/2025/developing-methods/virtual-reality-as-a-tool-to-map-the-emotional-side-of-pain 2026-02-03T16:42:41+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/virtual-reality-as-a-tool-to-map-the-emotional-side-of-pain/77771599da-1770133359/vr-paincart.jpg https://annualreport.chdr.nl/2025/developing-methods/ongoing-innovations-in-recording-electrical-brain-activity 2026-02-05T09:55:38+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/ongoing-innovations-in-recording-electrical-brain-activity/0bf87cf342-1770133235/chdr-rc-251603.jpg https://annualreport.chdr.nl/2025/developing-methods/successful-development-of-viral-infection-models 2026-02-05T10:01:35+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/successful-development-of-viral-infection-models/604b3cdcee-1770133394/ar2020_preview_070__mg_8354-1.jpg https://annualreport.chdr.nl/2025/developing-methods/oncology-group-builds-on-immunological-challenge-models 2026-02-05T16:21:34+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/oncology-group-builds-on-immunological-challenge-models/f9082e8754-1770133335/2018_derma_0112_preview.jpg https://annualreport.chdr.nl/2025/developing-methods/valuable-conclusions-from-existing-eeg-data 2026-02-03T16:39:21+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/valuable-conclusions-from-existing-eeg-data/79eb9a2462-1770133160/ar2024clinical_07.jpg https://annualreport.chdr.nl/2025/developing-methods/laying-the-foundation-for-a-new-approach-to-metabolic-studies 2026-02-05T10:18:13+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/laying-the-foundation-for-a-new-approach-to-metabolic-studies/acb70110d5-1770035517/wouter-keuris-fotografie-100-2.jpg https://annualreport.chdr.nl/2025/developing-methods/high-frequency-stimulation-a-novel-model-for-chronic-pain 2026-02-03T14:09:27+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/high-frequency-stimulation-a-novel-model-for-chronic-pain/ebd6ed431e-1770029695/chdr-rc-253170.jpg https://annualreport.chdr.nl/2025/developing-methods/bringing-one-of-the-most-informative-cns-testing-technologies-to-the-usa-dr-william-martin-ceo-lotus-clinical-research 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/bringing-one-of-the-most-informative-cns-testing-technologies-to-the-usa-dr-william-martin-ceo-lotus-clinical-research/9656d786a3-1770035326/bill-martin.jpg https://annualreport.chdr.nl/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology 2026-02-05T10:20:49+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology/e7e9de8070-1770036240/uvb-burn.png https://annualreport.chdr.nl/media/pages/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology/0509bf56fe-1770131516/uvb-rug.jpg https://annualreport.chdr.nl/2025/developing-methods/first-study-in-twente-focuses-on-measurements-of-excitability-of-the-motor-cortex 2026-02-05T16:17:57+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/first-study-in-twente-focuses-on-measurements-of-excitability-of-the-motor-cortex/ec8246edab-1770133303/chdr250708mdf011.jpg https://annualreport.chdr.nl/2025/developing-methods/candidate-biomarkers-for-sustained-dmt-effects 2026-02-05T10:39:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/candidate-biomarkers-for-sustained-dmt-effects/8e2853b93a-1770132838/mri-06-mq.jpg https://annualreport.chdr.nl/2025/developing-methods/chikungunya-model-ready-for-testing-vaccines-and-antivirals 2026-02-03T16:41:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/chikungunya-model-ready-for-testing-vaccines-and-antivirals/b9dce5bac0-1770133285/chdr-rc-252563.jpg https://annualreport.chdr.nl/2025/developing-people 2026-02-03T16:53:48+01:00 https://annualreport.chdr.nl/2025/developing-people/seven-new-phd-graduates-in-2025 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-people/seven-new-phd-graduates-in-2025/88c881c49e-1767706170/e1634945-1801-4a1b-99df-ae49b62b96fd.jpg https://annualreport.chdr.nl/media/pages/2025/developing-people/seven-new-phd-graduates-in-2025/bcc4289f10-1767706170/leiden-132_2.jpg https://annualreport.chdr.nl/2025/developing-people/clinical-pharmacology-trainees-develop-teaching-modules 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/developing-people/chdr-academy-firmly-embedded-in-the-organisation 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/developing-people/i-like-to-identify-the-root-of-a-problem-and-solve-it-together-with-others 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/developing-people/feeling-at-home-in-a-growing-organisation 2026-02-05T10:45:28+01:00 https://annualreport.chdr.nl/2025/stories 2026-02-03T16:55:44+01:00 https://annualreport.chdr.nl/2025/stories/operations-making-innovations-work 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/operations-making-innovations-work/80680eaf3d-1770034273/chdr-rc-252709.jpg https://annualreport.chdr.nl/2025/stories/new-gcp-guideline-based-on-a-fit-for-purpose-perspective 2026-02-05T10:49:24+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/new-gcp-guideline-based-on-a-fit-for-purpose-perspective/de1c3e33b5-1770284963/chdr-rc-252267.jpg https://annualreport.chdr.nl/2025/stories/roll-out-of-chdr-deep-phenotyping-approach-in-consortium-study 2026-02-05T10:47:23+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/roll-out-of-chdr-deep-phenotyping-approach-in-consortium-study/291c688f4e-1770284826/preview-0020-derma-lowres.jpg https://annualreport.chdr.nl/2025/stories/igor-radanovic-heads-chdr-s-oncology-initiative 2026-02-05T16:19:41+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/igor-radanovic-heads-chdr-s-oncology-initiative/e0cf07edd6-1770285170/chdr-rc-254038.jpg https://annualreport.chdr.nl/2025/stories/chdr-twente-pioneering-at-a-new-location 2026-02-05T11:16:34+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/chdr-twente-pioneering-at-a-new-location/3729b3232b-1770285240/chdr251010mdf049v2-1.jpg https://annualreport.chdr.nl/2025/stories/clusters-strengthen-internal-synergy 2026-02-10T16:26:47+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/clusters-strengthen-internal-synergy/e8c0d35bde-1770285203/untitled-design-4.jpg https://annualreport.chdr.nl/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven 2026-02-11T15:02:33+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven/cfd46e7c29-1770285291/afscheid-joop.jpg https://annualreport.chdr.nl/media/pages/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven/73f3557571-1770285269/afscheid-joop.webp https://annualreport.chdr.nl/2025/scientific-output 2026-02-03T16:56:06+01:00 https://annualreport.chdr.nl/2025/scientific-output/our-publications-in-2025 2026-02-10T17:32:26+01:00 https://annualreport.chdr.nl/media/pages/2025/scientific-output/our-publications-in-2025/3e80c66f8f-1767706170/ar-publicaties-2023.jpg https://annualreport.chdr.nl/2025/lost-in-translation-the-toll-like-receptor-7-induced-pharmacological-challenge-model-of-the-skin 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/ruben-meijer 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/titiaan-post 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/francis-dijkstra 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/ruben-houvast 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/ingrid-koopmans 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2025/laurence-moss 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/2024 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/2024/bas-van-kraaij 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/titia-ruijs 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/gert-jan-hassing 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/eva-thijssen 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/ahnjili-zhuparris 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/jannik-rousel 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/eveline-in-t-veld 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/mahdi-saghari 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/wouter-ten-voorde 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/2024-in-perspective 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/2024/2024-in-perspective/annual-report-2024-from-insights-to-impact 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years/1c133d0acd-1746023893/ar2024_21_anouk-geert-2.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years/95605ce0b5-1746023892/ar2024_21_anouk-geert.jpg https://annualreport.chdr.nl/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030 2026-02-03T14:09:31+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/ecd229be06-1746023897/annual-report-2015-0005-building-highres-1.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/9cffeba6ce-1746023895/jhml1306-7133.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/52f05871c7-1746023894/screenshot-of-building.png https://annualreport.chdr.nl/2024/2024-in-perspective/2024-in-numbers 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/2024-in-numbers/faa535d18b-1746023891/ar2024clinical_17_2048.jpg https://annualreport.chdr.nl/2024/developing-drugs 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/2024/developing-drugs/using-tms-and-eeg-to-study-a-novel-class-of-drug 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/using-tms-and-eeg-to-study-a-novel-class-of-drug/54cdeeebd4-1746023884/ar2018_methods_0049_tms-eeg-preview.jpg https://annualreport.chdr.nl/2024/developing-drugs/towards-a-novel-class-of-painkillers 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/towards-a-novel-class-of-painkillers/68b1dfd1e9-1746023885/clinical-unit-ro160923-590.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/towards-a-novel-class-of-painkillers/62ebf71c34-1746023885/clinical-unit-ro160923-603-1.jpg https://annualreport.chdr.nl/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/ed9638c29a-1746023888/ar2024_philip-kremer_02_e1a6445_2048.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/d7f93018b7-1746023888/clinical-unit-ro160923-827.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/d32af9aabb-1746023888/khansen-03_2048.jpg https://annualreport.chdr.nl/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain/998b5bebb0-1746023886/chdr-9v2-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain/d80b602bfa-1746023886/clinical-unit.png https://annualreport.chdr.nl/2024/developing-drugs/pharmacological-surprises-with-a-well-known-psychedelic-compound 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/pharmacological-surprises-with-a-well-known-psychedelic-compound/10559c1241-1746023883/ar2024_18_gabriel-jacobs.jpg https://annualreport.chdr.nl/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/0579053424-1746023890/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/b8845bbf1e-1746023889/chdr-8-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/e92eb9a992-1746023890/img_7761.jpeg https://annualreport.chdr.nl/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease/3cb8c2434f-1746023881/ar2018_methods_0106_derma-preview.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease/21dc49bab5-1746023883/wouter-keuris-fotografie-098.jpg https://annualreport.chdr.nl/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis/dbc399d8ef-1746023881/ar2023_epilepsie_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis/5dc64afd38-1746023880/contrast-vloeistof-0011-preview.jpg https://annualreport.chdr.nl/2024/developing-drugs/studying-novel-immunomodulatory-agents 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/studying-novel-immunomodulatory-agents/d6ec7796b6-1746023879/chdr-developing-drugs-b-v3.00_00_02_00.still001.jpg https://annualreport.chdr.nl/2024/developing-drugs/a-brilliant-example-of-an-early-proof-of-mechanism 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-brilliant-example-of-an-early-proof-of-mechanism/33b1d8a70f-1746023888/cru-1.jpg https://annualreport.chdr.nl/2024/developing-methods 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/2024/developing-methods/pharmacology-as-the-cornerstone-of-a-multidisciplinary-approach-to-psychedelic-therapies 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/2024/developing-methods/studies-involving-healthy-study-participants-can-provide-useful-information-in-immuno-oncology 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/studies-involving-healthy-study-participants-can-provide-useful-information-in-immuno-oncology/a1e34d368d-1746023908/ar2024_matthijs-moerland_02_e1a5964_2048.jpg https://annualreport.chdr.nl/2024/developing-methods/expanding-the-applications-for-immunological-challenge-models 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/expanding-the-applications-for-immunological-challenge-models/e86c34dd49-1746023907/2018_derma_0112_preview.jpg https://annualreport.chdr.nl/2024/developing-methods/biomarkers-for-neurodegenerative-diseases 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/biomarkers-for-neurodegenerative-diseases/8e4085dccb-1746023909/ar2024_philip-kremer_03_e1a6427_2048_select.jpg https://annualreport.chdr.nl/2024/developing-methods/machine-learning-to-unlock-insights-from-deep-phenotyping-data 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/machine-learning-to-unlock-insights-from-deep-phenotyping-data/93b48c1026-1746023898/2018_derma_0115_preview.jpg https://annualreport.chdr.nl/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/99df82596a-1746023903/ar2023_jannis_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/8f9a3be304-1746023903/ar2024_19_vasileios-exadaktylos.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/ff3673637f-1746023903/ar2024clinical_08.jpg https://annualreport.chdr.nl/2024/developing-methods/trial-home-promising-results-in-clinical-practice 2026-02-03T14:09:35+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/9d2baa8fc8-1746023902/annual-report-2015-0020-clinical-unit-hd-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/f016960980-1746023901/annual-report-2015-0020-clinical-unit-highres.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/3c167d450e-1746023902/in-dept-eeg-analysis.png https://annualreport.chdr.nl/2024/developing-methods/viral-infection-model-successfully-implemented 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/viral-infection-model-successfully-implemented/000191e7bc-1746023906/buisje.jpg https://annualreport.chdr.nl/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya/c95c3e8575-1746023899/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya/d7c8d955cb-1746023900/in-neus_01_00_00_04.jpg https://annualreport.chdr.nl/2024/developing-methods/developing-and-validating-biomarkers-for-chronic-pain 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/developing-and-validating-biomarkers-for-chronic-pain/519a7980f8-1746023904/preview-0056-pain-lowres.jpg https://annualreport.chdr.nl/2024/developing-methods/chdr-develops-measurements-for-fatty-liver-disease-and-weight-reduction 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/chdr-develops-measurements-for-fatty-liver-disease-and-weight-reduction/c85e4a3eb1-1746023905/ar2024_13_naomi-klarenbeek.jpg https://annualreport.chdr.nl/2024/developing-people 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations/961574345f-1746023914/e1634945-1801-4a1b-99df-ae49b62b96fd.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations/84ab70e5ff-1746023914/leiden-132_2.jpg https://annualreport.chdr.nl/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development/2188808fe1-1746023910/ar2023_maurits_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development/dcd8d388f7-1746023910/ar2024_09_koos-jeroen.jpg https://annualreport.chdr.nl/2024/developing-people/increasing-the-impact-of-the-trc-p-teaching-platform-for-students-and-professionals 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/increasing-the-impact-of-the-trc-p-teaching-platform-for-students-and-professionals/e33a161a8d-1746023913/ar2023_jeroen_002_2048.jpg https://annualreport.chdr.nl/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/8b2f1f5f72-1746023912/ar2023_noor_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/64992613e7-1746023912/ar2024_06_linda-aulin-3.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/02d4acf9a8-1746023911/ar2024_linda-aulin_06_e1a5092_2048_select.jpg https://annualreport.chdr.nl/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/332a8629bf-1746023916/ar2018_misc_0046-preview.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/f25f895c22-1746023916/ar2024_17_doesita-ramkoeber.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/4963851572-1746023916/ar2024_doesita-ramkoeber_03_e1a6159_2048.jpg https://annualreport.chdr.nl/2024/stories 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/2024/stories/collaborating-on-behalf-of-cancer-patients 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/collaborating-on-behalf-of-cancer-patients/2411128ac2-1746023878/ar2024_11_igor-radanovic.jpg https://annualreport.chdr.nl/media/pages/2024/stories/collaborating-on-behalf-of-cancer-patients/8f4b1a340c-1746023879/chdr-9909.jpg https://annualreport.chdr.nl/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/51249a3e17-1746023871/ar2023_christine_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/64b3522821-1746023871/ar2024_04_robert-rissman-1.jpg https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/e4cfd5b377-1746023870/ar2024_04_robert-rissman.jpg https://annualreport.chdr.nl/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium/ce971dbc95-1746023869/ar2023_planning_002.jpg https://annualreport.chdr.nl/media/pages/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium/856ffaff04-1746023868/p-p.png https://annualreport.chdr.nl/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity/a48d3e98bf-1746023873/ar2023_jules_002.jpg https://annualreport.chdr.nl/media/pages/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity/1808656257-1746023873/mst-1408x.jpg https://annualreport.chdr.nl/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career/0715907240-1746023867/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career/211bd647e1-1746023866/chdr2025-web-anouk-01-v1-1408x.jpg https://annualreport.chdr.nl/2024/stories/using-study-participants-feedback-to-improve-recruitment 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/e03180858a-1746023868/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/beafd93a7b-1746023867/branding-chdr.png https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/8ffaa70d4b-1746023867/lumc-unit-2.png https://annualreport.chdr.nl/2024/stories/culture-programme-in-implementation-phase 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/bcc6043a5a-1746023876/ar2024_03_christine-van-andel-1.jpg https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/a974144c60-1746023877/ar2024_03_christine-van-andel.jpg https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/53105d7018-1746023877/cultuur-programma.png https://annualreport.chdr.nl/2024/stories/feedback-driven-hr-strengthening-chdr-s-workforce 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/feedback-driven-hr-strengthening-chdr-s-workforce/a0e8ecbea7-1746023872/ar2024_03_christine-van-andel-1.jpg https://annualreport.chdr.nl/2024/stories/chdr-plays-key-role-in-national-infectious-diseases-facility 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/chdr-plays-key-role-in-national-infectious-diseases-facility/6e59766edf-1746023875/ar2024_16_ingrid.jpg https://annualreport.chdr.nl/2024/stories/marieke-niesters-appointed-as-head-of-the-pain-group 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/marieke-niesters-appointed-as-head-of-the-pain-group/cf95a37ce7-1746023874/ar2024_marieke-niesters_05_e1a4721_2048.jpg https://annualreport.chdr.nl/2024/scientific-output 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/2024/scientific-output/our-publications-in-2024 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/media/pages/2024/scientific-output/our-publications-in-2024/642ec97e4e-1746023897/ar-publicaties-2023.jpg https://annualreport.chdr.nl/2023 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/2023-in-perspective 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/2023-in-perspective/bridging-the-gap-to-the-future 2026-02-19T15:13:05+01:00 https://annualreport.chdr.nl/2023/2023-in-perspective/2023-in-numbers 2026-02-19T15:16:53+01:00 https://annualreport.chdr.nl/2023/developing-drugs 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis 2026-02-19T15:23:30+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis/fcfb25322a-1746023950/lancet-5.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis/bf08c91b58-1746023951/lancet-cover.png https://annualreport.chdr.nl/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too 2026-02-19T15:29:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too/8980a72621-1746023952/clinical-unit-ro160923-827.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too/35e182fc8a-1746023952/khansen-03_2048.jpg https://annualreport.chdr.nl/2023/developing-drugs/the-adventurous-journey-of-an-immunological-compound 2026-02-19T15:38:12+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/the-adventurous-journey-of-an-immunological-compound/21f9600b98-1746023958/ar2023_matthijs_001.jpg https://annualreport.chdr.nl/2023/developing-drugs/small-steps-towards-effective-treatments-in-neurodegenerative-disorders 2026-02-19T15:41:08+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/small-steps-towards-effective-treatments-in-neurodegenerative-disorders/a771642a1b-1746023954/ar2023_phillip_001.jpg https://annualreport.chdr.nl/2023/developing-drugs/the-spirit-of-the-collaboration-has-been-good 2026-02-19T15:46:41+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/the-spirit-of-the-collaboration-has-been-good/0f8e323970-1746023949/hm-picture-2.png https://annualreport.chdr.nl/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis 2026-02-19T15:51:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis/fd2f7f93d6-1746023957/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis/6fece640b4-1746023957/chdr-8-1.jpg https://annualreport.chdr.nl/2023/developing-drugs/we-ask-ourselves-what-would-give-us-confidence-to-take-the-next-step-dr-fabienne-schumacher-sanofi 2026-02-19T15:59:25+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/we-ask-ourselves-what-would-give-us-confidence-to-take-the-next-step-dr-fabienne-schumacher-sanofi/086920b23f-1746023956/ar2018_methods_0106_derma-preview.jpg https://annualreport.chdr.nl/2023/developing-drugs/sensitivity-to-light-flashes-used-in-antiepileptic-drug-development 2026-02-20T16:09:18+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/sensitivity-to-light-flashes-used-in-antiepileptic-drug-development/612db8d5e1-1746023958/ar2023_epilepsie_001.jpg https://annualreport.chdr.nl/2023/developing-drugs/painkiller-aimed-at-promising-target-now-studied-in-phase-iii-trial 2026-02-20T16:18:27+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/painkiller-aimed-at-promising-target-now-studied-in-phase-iii-trial/4357e9a7f2-1746023955/ar2021_mg_1312_preview.jpg https://annualreport.chdr.nl/2023/developing-drugs/reducing-respiratory-depression-without-affecting-anaesthesia 2026-02-20T16:23:24+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/reducing-respiratory-depression-without-affecting-anaesthesia/24b5b6196b-1746023954/cru-1.jpg https://annualreport.chdr.nl/2023/developing-methods 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/2023/developing-methods/what-can-oncology-research-teach-us-about-drug-development-in-psychiatry 2026-03-10T13:52:52+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/what-can-oncology-research-teach-us-about-drug-development-in-psychiatry/72907f608a-1746023938/ar2023_jannis_001.jpg https://annualreport.chdr.nl/2023/developing-methods/extracting-valuable-extra-information-from-the-eeg 2026-03-10T14:00:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/extracting-valuable-extra-information-from-the-eeg/cb7e59da9d-1746023938/in-dept-eeg-analysis.png https://annualreport.chdr.nl/2023/developing-methods/new-study-design-with-well-known-drug-for-chdr-s-first-integrative-oncology-study 2026-03-10T14:22:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/new-study-design-with-well-known-drug-for-chdr-s-first-integrative-oncology-study/55fe8bb497-1746023935/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/2023/developing-methods/deep-phenotyping-patients-to-improve-drug-development 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/deep-phenotyping-patients-to-improve-drug-development/32078431be-1746023939/cru-deep-pheno.jpg https://annualreport.chdr.nl/2023/developing-methods/new-tests-to-measure-drug-effects-on-psychological-functioning 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/new-tests-to-measure-drug-effects-on-psychological-functioning/c306e41bf6-1746023942/ar2023_ingrid_001.jpg https://annualreport.chdr.nl/2023/developing-methods/cns-profiler-will-facilitate-neurocart-studies-at-other-sites 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/cns-profiler-will-facilitate-neurocart-studies-at-other-sites/f939a43a30-1746023941/ar2023_vr_001.jpg https://annualreport.chdr.nl/2023/developing-methods/with-its-expertise-in-excitability-research-the-new-experimental-medicine-group-can-contribute-to-pain-research-and-the-developm 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/with-its-expertise-in-excitability-research-the-new-experimental-medicine-group-can-contribute-to-pain-research-and-the-developm/d59b96256e-1746023936/tms-eeg-2.jpg https://annualreport.chdr.nl/2023/developing-methods/rna-sequencing-bridges-preclinical-models-and-clinical-applications 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/rna-sequencing-bridges-preclinical-models-and-clinical-applications/20c55073c3-1746023940/lab-general.jpg https://annualreport.chdr.nl/2023/developing-methods/in-depth-profiling-of-mild-psoriasis-patients-paves-the-way-for-future-trials 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/in-depth-profiling-of-mild-psoriasis-patients-paves-the-way-for-future-trials/5e9d4916bd-1746023936/derma-toolbox.jpg https://annualreport.chdr.nl/2023/developing-methods/dopamine-novelty-and-motivation-an-academic-collaboration 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/dopamine-novelty-and-motivation-an-academic-collaboration/3925595a89-1746023943/ar2023_fsw_001.jpg https://annualreport.chdr.nl/2023/developing-methods/deep-phenotyping-is-core-aim-of-national-immunodermatology-consortium 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/deep-phenotyping-is-core-aim-of-national-immunodermatology-consortium/22f8fe0ce7-1746023934/derma-flower-4-right.png https://annualreport.chdr.nl/2023/developing-people 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/2023/developing-people/dr-maurits-vissers-new-clinical-operations-director 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/dr-maurits-vissers-new-clinical-operations-director/c4e7b5e360-1746023944/ar2023_maurits_001.jpg https://annualreport.chdr.nl/2023/developing-people/cutting-the-red-tape-for-clinical-pharmacology-internships 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/cutting-the-red-tape-for-clinical-pharmacology-internships/c1ede08a5d-1746023944/ar2023_jeroen_002_2048.jpg https://annualreport.chdr.nl/2023/developing-people/noor-lansbergen-went-from-administration-to-clinical-programming-i-am-very-happy-with-this-career-switch 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/noor-lansbergen-went-from-administration-to-clinical-programming-i-am-very-happy-with-this-career-switch/0043466792-1746023947/ar2023_noor_001.jpg https://annualreport.chdr.nl/2023/developing-people/tailored-education-for-chdr-clinical-scientists 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/tailored-education-for-chdr-clinical-scientists/ea9b663719-1746023946/ar2018_misc_0046-preview.jpg https://annualreport.chdr.nl/2023/developing-people/learning-new-things-and-team-building-in-barcelona 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/learning-new-things-and-team-building-in-barcelona/fa9d6a5a7f-1746023947/life-support-training.jpg https://annualreport.chdr.nl/2023/developing-people/eight-new-phd-graduates-in-2023 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/eight-new-phd-graduates-in-2023/81f290a2cb-1746023945/leiden-132_2.jpg https://annualreport.chdr.nl/2023/jonas-matthias-den-heijer 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/2023/stories 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/2023/stories/dr-naomi-klarenbeek-appointed-research-director-internal-medicine 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/dr-naomi-klarenbeek-appointed-research-director-internal-medicine/439742a90b-1746023927/ar2023_naomi_001.jpg https://annualreport.chdr.nl/2023/stories/new-experimental-medicine-group-looks-at-excitability-in-brain-muscle-and-peripheral-nerve 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-experimental-medicine-group-looks-at-excitability-in-brain-muscle-and-peripheral-nerve/87bee06870-1746023929/ar2023_jules_002.jpg https://annualreport.chdr.nl/2023/stories/chdr-opened-special-clinical-research-unit-within-the-lumc 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/chdr-opened-special-clinical-research-unit-within-the-lumc/18f0657cf7-1746023928/chdr-9909.jpg https://annualreport.chdr.nl/2023/stories/new-hr-director-christine-van-andel-warm-welcome-in-a-thriving-organisation 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-hr-director-christine-van-andel-warm-welcome-in-a-thriving-organisation/8dbac93f14-1746023925/ar2023_christine_001.jpg https://annualreport.chdr.nl/2023/stories/multi-resource-planning-and-recruitment-funnel-improved-operational-efficiency 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/multi-resource-planning-and-recruitment-funnel-improved-operational-efficiency/c5621bc4b0-1746023931/ar2023_planning_002.jpg https://annualreport.chdr.nl/2023/stories/campaign-aims-to-improve-the-image-of-clinical-drug-research 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/campaign-aims-to-improve-the-image-of-clinical-drug-research/526c8086a3-1746023924/ar2023_herbert_001.jpg https://annualreport.chdr.nl/2023/stories/building-a-new-concept-for-early-oncology-drug-development 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/building-a-new-concept-for-early-oncology-drug-development/d4d0e7b2b0-1746023930/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2023/stories/building-a-new-concept-for-early-oncology-drug-development/39ff8e8e9d-1746023930/lumc-unit-2.png https://annualreport.chdr.nl/2023/stories/pandemic-proof-initiative-for-infection-research 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/pandemic-proof-initiative-for-infection-research/cfad2a738a-1746023932/ar2020_preview_070__mg_8354-2.jpg https://annualreport.chdr.nl/2023/stories/new-collaborations-for-biomarker-engineering-and-analytics-group 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-collaborations-for-biomarker-engineering-and-analytics-group/9e1c3580aa-1746023933/ar2023_pharmacometrics_001.jpg https://annualreport.chdr.nl/2023/stories/working-group-devised-recommendations-for-an-organisation-with-a-unique-culture 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/working-group-devised-recommendations-for-an-organisation-with-a-unique-culture/fecbe5f5f9-1746023927/image-1.jpg https://annualreport.chdr.nl/2023/scientific-output 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2023/scientific-output/our-publications-in-2023 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/media/pages/2023/scientific-output/our-publications-in-2023/29a605c279-1746023959/ar-publicaties-2023.jpg https://annualreport.chdr.nl/2023/bertine-huisman 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2023/lisa-pagan 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2023/maurits-vissers 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/samantha-prins 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/victor-baart 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/wieke-grievink 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/johan-van-der-plas 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2023/willem-birkhoff 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/2022 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/developing-methods 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/developing-methods/deep-phenotyping-mycosis-fungoides-profiling-an-orphan-malignancy 2026-02-18T14:26:22+01:00 https://annualreport.chdr.nl/2022/developing-methods/developing-biomarkers-to-study-drugs-for-neurodegenerative-diseases 2026-02-18T14:36:40+01:00 https://annualreport.chdr.nl/2022/developing-methods/laying-the-foundations-for-faster-vaccine-development 2026-02-18T15:01:19+01:00 https://annualreport.chdr.nl/2022/developing-methods/the-search-for-human-complement-challenge-models 2026-02-18T15:06:13+01:00 https://annualreport.chdr.nl/2022/developing-methods/assessing-the-pharmacokinetics-of-large-molecules-in-the-cns 2026-02-18T15:10:31+01:00 https://annualreport.chdr.nl/2022/developing-methods/bone-marrow-aspiration-biopsy-and-laboratory-analysis 2026-02-18T15:15:16+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-methods/bone-marrow-aspiration-biopsy-and-laboratory-analysis/0fcade096d-1746023972/ar2022_014.jpg https://annualreport.chdr.nl/2022/developing-methods/developing-and-validating-a-finger-tapping-test-for-parkinson-s-disease 2026-02-18T15:34:01+01:00 https://annualreport.chdr.nl/2022/developing-people 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/developing-people/leaders-in-pharmacology-education-from-primary-school-to-professional-training 2026-02-18T16:22:27+01:00 https://annualreport.chdr.nl/2022/developing-people/collaborating-to-grow-the-human-resources-potential-of-the-leiden-bio-science-park 2026-02-18T16:26:03+01:00 https://annualreport.chdr.nl/2022/developing-people/prof-geert-jan-groeneveld-the-revolution-in-neuropharmacology-is-underway 2026-02-18T16:32:46+01:00 https://annualreport.chdr.nl/2022/developing-people/on-the-right-path-career-development-at-chdr 2026-02-18T16:34:30+01:00 https://annualreport.chdr.nl/2022/developing-people/prof-robert-rissmann-the-golden-hour-of-dermatology-is-just-beginning 2026-02-18T16:35:40+01:00 https://annualreport.chdr.nl/2022/developing-people/five-new-phd-graduates-in-2022 2026-02-18T16:37:05+01:00 https://annualreport.chdr.nl/2022/2022-in-perspective 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/2022-in-perspective/message-from-the-executive-board 2026-02-18T13:16:46+01:00 https://annualreport.chdr.nl/2022/2022-in-perspective/2022-in-numbers 2026-02-18T13:21:32+01:00 https://annualreport.chdr.nl/2022/developing-drugs 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/developing-drugs/profiling-novel-gaba-agonists 2026-02-18T14:10:46+01:00 https://annualreport.chdr.nl/2022/developing-drugs/sponsor-interview-dr-beate-rohde-bayer 2026-02-18T13:32:14+01:00 https://annualreport.chdr.nl/2022/developing-drugs/patients-and-healthy-volunteers-in-an-integrative-approach-to-drug-development-in-oncology 2026-02-18T13:38:33+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-drugs/patients-and-healthy-volunteers-in-an-integrative-approach-to-drug-development-in-oncology/1441fccd41-1746023970/ar2022_003_cropped.jpg https://annualreport.chdr.nl/2022/developing-drugs/it-s-been-a-fantastic-journey-dr-thomas-holm-pedersen-nmd-pharma 2026-02-18T13:44:21+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-drugs/it-s-been-a-fantastic-journey-dr-thomas-holm-pedersen-nmd-pharma/76689f8805-1746023969/nmd_pharma_thomas_holm_pedersen_small.jpg https://annualreport.chdr.nl/2022/developing-drugs/unlocking-the-potential-of-psychedelic-compounds-in-psychiatry 2026-02-18T14:04:00+01:00 https://annualreport.chdr.nl/2022/developing-drugs/sponsor-interview-dr-rachel-gurrell-noema-pharma 2026-02-18T14:10:31+01:00 https://annualreport.chdr.nl/2022/developing-drugs/chdr-is-an-active-and-innovative-research-partner-peter-van-der-ark-janssen 2026-02-18T14:23:43+01:00 https://annualreport.chdr.nl/2022/https-chdr-nl-library-genetic-and-clinical-pharmacology-studies-in-gba1-associated-parkinson-s-disease-download 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/2022-stories 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/2022-stories/35-years-of-creating-value-in-an-unpredictable-world 2026-02-18T16:40:16+01:00 https://annualreport.chdr.nl/2022/2022-stories/fully-prepared-for-the-european-clinical-trials-regulation 2026-02-18T16:41:21+01:00 https://annualreport.chdr.nl/2022/2022-stories/new-compensation-guidelines-improve-study-recruitment 2026-02-18T16:55:12+01:00 https://annualreport.chdr.nl/2022/2022-stories/prestigious-grant-awarded-to-national-immunodermatology-consortium 2026-02-18T16:58:10+01:00 https://annualreport.chdr.nl/2022/2022-stories/1-000th-patient-with-atopic-dermatitis-recruited 2026-02-18T17:02:09+01:00 https://annualreport.chdr.nl/2022/publications 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/publications/our-publications-in-2022 2026-02-18T17:03:21+01:00 https://annualreport.chdr.nl/2022/thesis-hein-van-der-wall 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/thesis-josine-vrouwe 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/thesis-matthijs-kruizinga 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/2022/thesis-hemme-hijma 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/overview 2026-02-05T11:22:49+01:00 https://annualreport.chdr.nl/en/2025 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/en/2025/2025-in-perspective 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/2025-in-perspective/annual-report-2025-where-innovation-meets-application 2026-02-05T10:12:39+01:00 https://annualreport.chdr.nl/en/2025/2025-in-perspective/investing-in-future-success 2026-02-05T09:46:33+01:00 https://annualreport.chdr.nl/en/2025/2025-in-perspective/2025-in-numbers 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/2025-in-perspective/2025-in-numbers/e66dd9baa3-1767706170/ar2024clinical_17_2048.jpg https://annualreport.chdr.nl/en/2025/bas-van-kraaij 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/titia-ruijs 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/gert-jan-hassing 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/eva-thijssen 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/ahnjili-zhuparris 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/jannik-rousel 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/eveline-in-t-veld 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/mahdi-saghari 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/wouter-ten-voorde 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/en/2025/developing-drugs 2026-02-03T16:55:23+01:00 https://annualreport.chdr.nl/en/2025/developing-drugs/neurokit-test-used-in-the-united-kingdom 2026-02-05T09:51:35+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/neurokit-test-used-in-the-united-kingdom/a7a3377772-1770132144/ar2024clinical_13.jpg https://annualreport.chdr.nl/en/2025/developing-drugs/reproducible-results-thanks-to-objective-measurements-dr-gerard-marek-gilgamesh-pharma 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/reproducible-results-thanks-to-objective-measurements-dr-gerard-marek-gilgamesh-pharma/bf12258d82-1770046968/generated-image.png https://annualreport.chdr.nl/en/2025/developing-drugs/complex-study-provided-insight-into-immunological-pathways 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/en/2025/developing-drugs/the-next-step-in-an-immunological-journey-of-discovery-professor-frederic-triebel-immutep 2026-02-03T16:17:19+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/the-next-step-in-an-immunological-journey-of-discovery-professor-frederic-triebel-immutep/4a7ade0b7d-1770029062/triebel.jpg https://annualreport.chdr.nl/en/2025/developing-drugs/favourable-results-for-ampa-pam-osavampator 2026-02-03T16:21:36+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/favourable-results-for-ampa-pam-osavampator/bfac35dbcd-1770132094/chdr-rc-253031.jpg https://annualreport.chdr.nl/en/2025/developing-drugs/novel-treatments-for-patients-with-atopic-dermatitis 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-treatments-for-patients-with-atopic-dermatitis/718a34f7b8-1770028629/chatgpt-image-feb-2-2026-11_36_46-am.png https://annualreport.chdr.nl/en/2025/developing-drugs/promising-results-from-a-novel-psychedelic-compound 2026-02-03T16:22:06+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/promising-results-from-a-novel-psychedelic-compound/44ac96df51-1770132125/ar2024clinical_02.jpg https://annualreport.chdr.nl/en/2025/developing-drugs/new-co2-challenge-setup-ready-for-proof-of-mechanism-studies-with-anxiolytic-drugs 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/en/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients 2026-02-03T16:15:20+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients/80df40d53c-1770028865/chatgpt-image-feb-2-2026-11_40_31-am.png https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients/7328edb453-1770131719/ra-patient.jpg https://annualreport.chdr.nl/en/2025/developing-drugs/successful-next-step-for-potential-treatment-of-frontotemporal-dementia 2026-02-03T16:26:04+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/successful-next-step-for-potential-treatment-of-frontotemporal-dementia/dbc02f7017-1770132362/chdr-rc-252444.jpg https://annualreport.chdr.nl/en/2025/developing-drugs/genotyped-cohort-facilitates-recruitment-for-studies-in-parkinson-s-disease 2026-02-05T09:35:23+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/genotyped-cohort-facilitates-recruitment-for-studies-in-parkinson-s-disease/5e2b29d4ab-1770280518/parkinson-swab-studie.jpg https://annualreport.chdr.nl/en/2025/developing-methods 2026-02-03T14:09:27+01:00 https://annualreport.chdr.nl/en/2025/developing-methods/neurokit-ready-for-clinical-studies-in-the-usa 2026-02-05T09:52:37+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/neurokit-ready-for-clinical-studies-in-the-usa/763d2e0bf5-1770133178/neurokit-usa.jpg https://annualreport.chdr.nl/en/2025/developing-methods/utility-function-ranks-opioids 2026-02-03T16:40:14+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/utility-function-ranks-opioids/94b1fec884-1770133213/chdr-rc-252569.jpg https://annualreport.chdr.nl/en/2025/developing-methods/in-depth-insight-into-immunological-challenge-models-allows-for-tailor-made-approach 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/in-depth-insight-into-immunological-challenge-models-allows-for-tailor-made-approach/9917e24c6a-1770029497/chdr-rc-252103.jpg https://annualreport.chdr.nl/en/2025/developing-methods/virtual-reality-as-a-tool-to-map-the-emotional-side-of-pain 2026-02-03T16:42:41+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/virtual-reality-as-a-tool-to-map-the-emotional-side-of-pain/77771599da-1770133359/vr-paincart.jpg https://annualreport.chdr.nl/en/2025/developing-methods/ongoing-innovations-in-recording-electrical-brain-activity 2026-02-05T09:55:38+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/ongoing-innovations-in-recording-electrical-brain-activity/0bf87cf342-1770133235/chdr-rc-251603.jpg https://annualreport.chdr.nl/en/2025/developing-methods/successful-development-of-viral-infection-models 2026-02-05T10:01:35+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/successful-development-of-viral-infection-models/604b3cdcee-1770133394/ar2020_preview_070__mg_8354-1.jpg https://annualreport.chdr.nl/en/2025/developing-methods/oncology-group-builds-on-immunological-challenge-models 2026-02-05T16:21:34+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/oncology-group-builds-on-immunological-challenge-models/f9082e8754-1770133335/2018_derma_0112_preview.jpg https://annualreport.chdr.nl/en/2025/developing-methods/valuable-conclusions-from-existing-eeg-data 2026-02-03T16:39:21+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/valuable-conclusions-from-existing-eeg-data/79eb9a2462-1770133160/ar2024clinical_07.jpg https://annualreport.chdr.nl/en/2025/developing-methods/laying-the-foundation-for-a-new-approach-to-metabolic-studies 2026-02-05T10:18:13+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/laying-the-foundation-for-a-new-approach-to-metabolic-studies/acb70110d5-1770035517/wouter-keuris-fotografie-100-2.jpg https://annualreport.chdr.nl/en/2025/developing-methods/high-frequency-stimulation-a-novel-model-for-chronic-pain 2026-02-03T14:09:27+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/high-frequency-stimulation-a-novel-model-for-chronic-pain/ebd6ed431e-1770029695/chdr-rc-253170.jpg https://annualreport.chdr.nl/en/2025/developing-methods/bringing-one-of-the-most-informative-cns-testing-technologies-to-the-usa-dr-william-martin-ceo-lotus-clinical-research 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/bringing-one-of-the-most-informative-cns-testing-technologies-to-the-usa-dr-william-martin-ceo-lotus-clinical-research/9656d786a3-1770035326/bill-martin.jpg https://annualreport.chdr.nl/en/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology 2026-02-05T10:20:49+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology/e7e9de8070-1770036240/uvb-burn.png https://annualreport.chdr.nl/media/pages/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology/0509bf56fe-1770131516/uvb-rug.jpg https://annualreport.chdr.nl/en/2025/developing-methods/first-study-in-twente-focuses-on-measurements-of-excitability-of-the-motor-cortex 2026-02-05T16:17:57+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/first-study-in-twente-focuses-on-measurements-of-excitability-of-the-motor-cortex/ec8246edab-1770133303/chdr250708mdf011.jpg https://annualreport.chdr.nl/en/2025/developing-methods/candidate-biomarkers-for-sustained-dmt-effects 2026-02-05T10:39:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/candidate-biomarkers-for-sustained-dmt-effects/8e2853b93a-1770132838/mri-06-mq.jpg https://annualreport.chdr.nl/en/2025/developing-methods/chikungunya-model-ready-for-testing-vaccines-and-antivirals 2026-02-03T16:41:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/chikungunya-model-ready-for-testing-vaccines-and-antivirals/b9dce5bac0-1770133285/chdr-rc-252563.jpg https://annualreport.chdr.nl/en/2025/developing-people 2026-02-03T16:53:48+01:00 https://annualreport.chdr.nl/en/2025/developing-people/seven-new-phd-graduates-in-2025 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-people/seven-new-phd-graduates-in-2025/88c881c49e-1767706170/e1634945-1801-4a1b-99df-ae49b62b96fd.jpg https://annualreport.chdr.nl/media/pages/2025/developing-people/seven-new-phd-graduates-in-2025/bcc4289f10-1767706170/leiden-132_2.jpg https://annualreport.chdr.nl/en/2025/developing-people/clinical-pharmacology-trainees-develop-teaching-modules 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/developing-people/chdr-academy-firmly-embedded-in-the-organisation 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/developing-people/i-like-to-identify-the-root-of-a-problem-and-solve-it-together-with-others 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/developing-people/feeling-at-home-in-a-growing-organisation 2026-02-05T10:45:28+01:00 https://annualreport.chdr.nl/en/2025/stories 2026-02-03T16:55:44+01:00 https://annualreport.chdr.nl/en/2025/stories/operations-making-innovations-work 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/operations-making-innovations-work/80680eaf3d-1770034273/chdr-rc-252709.jpg https://annualreport.chdr.nl/en/2025/stories/new-gcp-guideline-based-on-a-fit-for-purpose-perspective 2026-02-05T10:49:24+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/new-gcp-guideline-based-on-a-fit-for-purpose-perspective/de1c3e33b5-1770284963/chdr-rc-252267.jpg https://annualreport.chdr.nl/en/2025/stories/roll-out-of-chdr-deep-phenotyping-approach-in-consortium-study 2026-02-05T10:47:23+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/roll-out-of-chdr-deep-phenotyping-approach-in-consortium-study/291c688f4e-1770284826/preview-0020-derma-lowres.jpg https://annualreport.chdr.nl/en/2025/stories/igor-radanovic-heads-chdr-s-oncology-initiative 2026-02-05T16:19:41+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/igor-radanovic-heads-chdr-s-oncology-initiative/e0cf07edd6-1770285170/chdr-rc-254038.jpg https://annualreport.chdr.nl/en/2025/stories/chdr-twente-pioneering-at-a-new-location 2026-02-05T11:16:34+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/chdr-twente-pioneering-at-a-new-location/3729b3232b-1770285240/chdr251010mdf049v2-1.jpg https://annualreport.chdr.nl/en/2025/stories/clusters-strengthen-internal-synergy 2026-02-10T16:26:47+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/clusters-strengthen-internal-synergy/e8c0d35bde-1770285203/untitled-design-4.jpg https://annualreport.chdr.nl/en/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven 2026-02-11T15:02:33+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven/cfd46e7c29-1770285291/afscheid-joop.jpg https://annualreport.chdr.nl/media/pages/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven/73f3557571-1770285269/afscheid-joop.webp https://annualreport.chdr.nl/en/2025/scientific-output 2026-02-03T16:56:06+01:00 https://annualreport.chdr.nl/en/2025/scientific-output/our-publications-in-2025 2026-02-10T17:32:26+01:00 https://annualreport.chdr.nl/media/pages/2025/scientific-output/our-publications-in-2025/3e80c66f8f-1767706170/ar-publicaties-2023.jpg https://annualreport.chdr.nl/en/2025/lost-in-translation-the-toll-like-receptor-7-induced-pharmacological-challenge-model-of-the-skin 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/ruben-meijer 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/titiaan-post 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/francis-dijkstra 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/ruben-houvast 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/ingrid-koopmans 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2025/laurence-moss 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/en/2024 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/en/2024/bas-van-kraaij 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/titia-ruijs 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/gert-jan-hassing 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/eva-thijssen 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/ahnjili-zhuparris 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/jannik-rousel 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/eveline-in-t-veld 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/mahdi-saghari 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/wouter-ten-voorde 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/2024-in-perspective 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/en/2024/2024-in-perspective/annual-report-2024-from-insights-to-impact 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/en/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years/1c133d0acd-1746023893/ar2024_21_anouk-geert-2.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years/95605ce0b5-1746023892/ar2024_21_anouk-geert.jpg https://annualreport.chdr.nl/en/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030 2026-02-03T14:09:31+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/ecd229be06-1746023897/annual-report-2015-0005-building-highres-1.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/9cffeba6ce-1746023895/jhml1306-7133.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/52f05871c7-1746023894/screenshot-of-building.png https://annualreport.chdr.nl/en/2024/2024-in-perspective/2024-in-numbers 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/2024-in-numbers/faa535d18b-1746023891/ar2024clinical_17_2048.jpg https://annualreport.chdr.nl/en/2024/developing-drugs 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/en/2024/developing-drugs/using-tms-and-eeg-to-study-a-novel-class-of-drug 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/using-tms-and-eeg-to-study-a-novel-class-of-drug/54cdeeebd4-1746023884/ar2018_methods_0049_tms-eeg-preview.jpg https://annualreport.chdr.nl/en/2024/developing-drugs/towards-a-novel-class-of-painkillers 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/towards-a-novel-class-of-painkillers/68b1dfd1e9-1746023885/clinical-unit-ro160923-590.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/towards-a-novel-class-of-painkillers/62ebf71c34-1746023885/clinical-unit-ro160923-603-1.jpg https://annualreport.chdr.nl/en/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/ed9638c29a-1746023888/ar2024_philip-kremer_02_e1a6445_2048.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/d7f93018b7-1746023888/clinical-unit-ro160923-827.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/d32af9aabb-1746023888/khansen-03_2048.jpg https://annualreport.chdr.nl/en/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain/998b5bebb0-1746023886/chdr-9v2-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain/d80b602bfa-1746023886/clinical-unit.png https://annualreport.chdr.nl/en/2024/developing-drugs/pharmacological-surprises-with-a-well-known-psychedelic-compound 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/pharmacological-surprises-with-a-well-known-psychedelic-compound/10559c1241-1746023883/ar2024_18_gabriel-jacobs.jpg https://annualreport.chdr.nl/en/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/0579053424-1746023890/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/b8845bbf1e-1746023889/chdr-8-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/e92eb9a992-1746023890/img_7761.jpeg https://annualreport.chdr.nl/en/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease/3cb8c2434f-1746023881/ar2018_methods_0106_derma-preview.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease/21dc49bab5-1746023883/wouter-keuris-fotografie-098.jpg https://annualreport.chdr.nl/en/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis/dbc399d8ef-1746023881/ar2023_epilepsie_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis/5dc64afd38-1746023880/contrast-vloeistof-0011-preview.jpg https://annualreport.chdr.nl/en/2024/developing-drugs/studying-novel-immunomodulatory-agents 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/studying-novel-immunomodulatory-agents/d6ec7796b6-1746023879/chdr-developing-drugs-b-v3.00_00_02_00.still001.jpg https://annualreport.chdr.nl/en/2024/developing-drugs/a-brilliant-example-of-an-early-proof-of-mechanism 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-brilliant-example-of-an-early-proof-of-mechanism/33b1d8a70f-1746023888/cru-1.jpg https://annualreport.chdr.nl/en/2024/developing-methods 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/en/2024/developing-methods/pharmacology-as-the-cornerstone-of-a-multidisciplinary-approach-to-psychedelic-therapies 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/en/2024/developing-methods/studies-involving-healthy-study-participants-can-provide-useful-information-in-immuno-oncology 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/studies-involving-healthy-study-participants-can-provide-useful-information-in-immuno-oncology/a1e34d368d-1746023908/ar2024_matthijs-moerland_02_e1a5964_2048.jpg https://annualreport.chdr.nl/en/2024/developing-methods/expanding-the-applications-for-immunological-challenge-models 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/expanding-the-applications-for-immunological-challenge-models/e86c34dd49-1746023907/2018_derma_0112_preview.jpg https://annualreport.chdr.nl/en/2024/developing-methods/biomarkers-for-neurodegenerative-diseases 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/biomarkers-for-neurodegenerative-diseases/8e4085dccb-1746023909/ar2024_philip-kremer_03_e1a6427_2048_select.jpg https://annualreport.chdr.nl/en/2024/developing-methods/machine-learning-to-unlock-insights-from-deep-phenotyping-data 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/machine-learning-to-unlock-insights-from-deep-phenotyping-data/93b48c1026-1746023898/2018_derma_0115_preview.jpg https://annualreport.chdr.nl/en/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/99df82596a-1746023903/ar2023_jannis_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/8f9a3be304-1746023903/ar2024_19_vasileios-exadaktylos.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/ff3673637f-1746023903/ar2024clinical_08.jpg https://annualreport.chdr.nl/en/2024/developing-methods/trial-home-promising-results-in-clinical-practice 2026-02-03T14:09:35+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/9d2baa8fc8-1746023902/annual-report-2015-0020-clinical-unit-hd-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/f016960980-1746023901/annual-report-2015-0020-clinical-unit-highres.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/3c167d450e-1746023902/in-dept-eeg-analysis.png https://annualreport.chdr.nl/en/2024/developing-methods/viral-infection-model-successfully-implemented 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/viral-infection-model-successfully-implemented/000191e7bc-1746023906/buisje.jpg https://annualreport.chdr.nl/en/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya/c95c3e8575-1746023899/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya/d7c8d955cb-1746023900/in-neus_01_00_00_04.jpg https://annualreport.chdr.nl/en/2024/developing-methods/developing-and-validating-biomarkers-for-chronic-pain 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/developing-and-validating-biomarkers-for-chronic-pain/519a7980f8-1746023904/preview-0056-pain-lowres.jpg https://annualreport.chdr.nl/en/2024/developing-methods/chdr-develops-measurements-for-fatty-liver-disease-and-weight-reduction 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/chdr-develops-measurements-for-fatty-liver-disease-and-weight-reduction/c85e4a3eb1-1746023905/ar2024_13_naomi-klarenbeek.jpg https://annualreport.chdr.nl/en/2024/developing-people 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/en/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations/961574345f-1746023914/e1634945-1801-4a1b-99df-ae49b62b96fd.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations/84ab70e5ff-1746023914/leiden-132_2.jpg https://annualreport.chdr.nl/en/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development/2188808fe1-1746023910/ar2023_maurits_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development/dcd8d388f7-1746023910/ar2024_09_koos-jeroen.jpg https://annualreport.chdr.nl/en/2024/developing-people/increasing-the-impact-of-the-trc-p-teaching-platform-for-students-and-professionals 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/increasing-the-impact-of-the-trc-p-teaching-platform-for-students-and-professionals/e33a161a8d-1746023913/ar2023_jeroen_002_2048.jpg https://annualreport.chdr.nl/en/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/8b2f1f5f72-1746023912/ar2023_noor_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/64992613e7-1746023912/ar2024_06_linda-aulin-3.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/02d4acf9a8-1746023911/ar2024_linda-aulin_06_e1a5092_2048_select.jpg https://annualreport.chdr.nl/en/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/332a8629bf-1746023916/ar2018_misc_0046-preview.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/f25f895c22-1746023916/ar2024_17_doesita-ramkoeber.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/4963851572-1746023916/ar2024_doesita-ramkoeber_03_e1a6159_2048.jpg https://annualreport.chdr.nl/en/2024/stories 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/en/2024/stories/collaborating-on-behalf-of-cancer-patients 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/collaborating-on-behalf-of-cancer-patients/2411128ac2-1746023878/ar2024_11_igor-radanovic.jpg https://annualreport.chdr.nl/media/pages/2024/stories/collaborating-on-behalf-of-cancer-patients/8f4b1a340c-1746023879/chdr-9909.jpg https://annualreport.chdr.nl/en/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/51249a3e17-1746023871/ar2023_christine_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/64b3522821-1746023871/ar2024_04_robert-rissman-1.jpg https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/e4cfd5b377-1746023870/ar2024_04_robert-rissman.jpg https://annualreport.chdr.nl/en/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium/ce971dbc95-1746023869/ar2023_planning_002.jpg https://annualreport.chdr.nl/media/pages/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium/856ffaff04-1746023868/p-p.png https://annualreport.chdr.nl/en/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity/a48d3e98bf-1746023873/ar2023_jules_002.jpg https://annualreport.chdr.nl/media/pages/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity/1808656257-1746023873/mst-1408x.jpg https://annualreport.chdr.nl/en/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career/0715907240-1746023867/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career/211bd647e1-1746023866/chdr2025-web-anouk-01-v1-1408x.jpg https://annualreport.chdr.nl/en/2024/stories/using-study-participants-feedback-to-improve-recruitment 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/e03180858a-1746023868/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/beafd93a7b-1746023867/branding-chdr.png https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/8ffaa70d4b-1746023867/lumc-unit-2.png https://annualreport.chdr.nl/en/2024/stories/culture-programme-in-implementation-phase 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/bcc6043a5a-1746023876/ar2024_03_christine-van-andel-1.jpg https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/a974144c60-1746023877/ar2024_03_christine-van-andel.jpg https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/53105d7018-1746023877/cultuur-programma.png https://annualreport.chdr.nl/en/2024/stories/feedback-driven-hr-strengthening-chdr-s-workforce 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/feedback-driven-hr-strengthening-chdr-s-workforce/a0e8ecbea7-1746023872/ar2024_03_christine-van-andel-1.jpg https://annualreport.chdr.nl/en/2024/stories/chdr-plays-key-role-in-national-infectious-diseases-facility 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/chdr-plays-key-role-in-national-infectious-diseases-facility/6e59766edf-1746023875/ar2024_16_ingrid.jpg https://annualreport.chdr.nl/en/2024/stories/marieke-niesters-appointed-as-head-of-the-pain-group 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/marieke-niesters-appointed-as-head-of-the-pain-group/cf95a37ce7-1746023874/ar2024_marieke-niesters_05_e1a4721_2048.jpg https://annualreport.chdr.nl/en/2024/scientific-output 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/en/2024/scientific-output/our-publications-in-2024 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/media/pages/2024/scientific-output/our-publications-in-2024/642ec97e4e-1746023897/ar-publicaties-2023.jpg https://annualreport.chdr.nl/en/2023 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/2023-in-perspective 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/2023-in-perspective/bridging-the-gap-to-the-future 2026-02-19T15:13:05+01:00 https://annualreport.chdr.nl/en/2023/2023-in-perspective/2023-in-numbers 2026-02-19T15:16:53+01:00 https://annualreport.chdr.nl/en/2023/developing-drugs 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis 2026-02-19T15:23:30+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis/fcfb25322a-1746023950/lancet-5.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis/bf08c91b58-1746023951/lancet-cover.png https://annualreport.chdr.nl/en/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too 2026-02-19T15:29:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too/8980a72621-1746023952/clinical-unit-ro160923-827.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too/35e182fc8a-1746023952/khansen-03_2048.jpg https://annualreport.chdr.nl/en/2023/developing-drugs/the-adventurous-journey-of-an-immunological-compound 2026-02-19T15:38:12+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/the-adventurous-journey-of-an-immunological-compound/21f9600b98-1746023958/ar2023_matthijs_001.jpg https://annualreport.chdr.nl/en/2023/developing-drugs/small-steps-towards-effective-treatments-in-neurodegenerative-disorders 2026-02-19T15:41:08+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/small-steps-towards-effective-treatments-in-neurodegenerative-disorders/a771642a1b-1746023954/ar2023_phillip_001.jpg https://annualreport.chdr.nl/en/2023/developing-drugs/the-spirit-of-the-collaboration-has-been-good 2026-02-19T15:46:41+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/the-spirit-of-the-collaboration-has-been-good/0f8e323970-1746023949/hm-picture-2.png https://annualreport.chdr.nl/en/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis 2026-02-19T15:51:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis/fd2f7f93d6-1746023957/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis/6fece640b4-1746023957/chdr-8-1.jpg https://annualreport.chdr.nl/en/2023/developing-drugs/we-ask-ourselves-what-would-give-us-confidence-to-take-the-next-step-dr-fabienne-schumacher-sanofi 2026-02-19T15:59:25+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/we-ask-ourselves-what-would-give-us-confidence-to-take-the-next-step-dr-fabienne-schumacher-sanofi/086920b23f-1746023956/ar2018_methods_0106_derma-preview.jpg https://annualreport.chdr.nl/en/2023/developing-drugs/sensitivity-to-light-flashes-used-in-antiepileptic-drug-development 2026-02-20T16:09:18+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/sensitivity-to-light-flashes-used-in-antiepileptic-drug-development/612db8d5e1-1746023958/ar2023_epilepsie_001.jpg https://annualreport.chdr.nl/en/2023/developing-drugs/painkiller-aimed-at-promising-target-now-studied-in-phase-iii-trial 2026-02-20T16:18:27+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/painkiller-aimed-at-promising-target-now-studied-in-phase-iii-trial/4357e9a7f2-1746023955/ar2021_mg_1312_preview.jpg https://annualreport.chdr.nl/en/2023/developing-drugs/reducing-respiratory-depression-without-affecting-anaesthesia 2026-02-20T16:23:24+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/reducing-respiratory-depression-without-affecting-anaesthesia/24b5b6196b-1746023954/cru-1.jpg https://annualreport.chdr.nl/en/2023/developing-methods 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/en/2023/developing-methods/what-can-oncology-research-teach-us-about-drug-development-in-psychiatry 2026-03-10T13:52:52+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/what-can-oncology-research-teach-us-about-drug-development-in-psychiatry/72907f608a-1746023938/ar2023_jannis_001.jpg https://annualreport.chdr.nl/en/2023/developing-methods/extracting-valuable-extra-information-from-the-eeg 2026-03-10T14:00:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/extracting-valuable-extra-information-from-the-eeg/cb7e59da9d-1746023938/in-dept-eeg-analysis.png https://annualreport.chdr.nl/en/2023/developing-methods/new-study-design-with-well-known-drug-for-chdr-s-first-integrative-oncology-study 2026-03-10T14:22:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/new-study-design-with-well-known-drug-for-chdr-s-first-integrative-oncology-study/55fe8bb497-1746023935/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/en/2023/developing-methods/deep-phenotyping-patients-to-improve-drug-development 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/deep-phenotyping-patients-to-improve-drug-development/32078431be-1746023939/cru-deep-pheno.jpg https://annualreport.chdr.nl/en/2023/developing-methods/new-tests-to-measure-drug-effects-on-psychological-functioning 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/new-tests-to-measure-drug-effects-on-psychological-functioning/c306e41bf6-1746023942/ar2023_ingrid_001.jpg https://annualreport.chdr.nl/en/2023/developing-methods/cns-profiler-will-facilitate-neurocart-studies-at-other-sites 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/cns-profiler-will-facilitate-neurocart-studies-at-other-sites/f939a43a30-1746023941/ar2023_vr_001.jpg https://annualreport.chdr.nl/en/2023/developing-methods/with-its-expertise-in-excitability-research-the-new-experimental-medicine-group-can-contribute-to-pain-research-and-the-developm 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/with-its-expertise-in-excitability-research-the-new-experimental-medicine-group-can-contribute-to-pain-research-and-the-developm/d59b96256e-1746023936/tms-eeg-2.jpg https://annualreport.chdr.nl/en/2023/developing-methods/rna-sequencing-bridges-preclinical-models-and-clinical-applications 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/rna-sequencing-bridges-preclinical-models-and-clinical-applications/20c55073c3-1746023940/lab-general.jpg https://annualreport.chdr.nl/en/2023/developing-methods/in-depth-profiling-of-mild-psoriasis-patients-paves-the-way-for-future-trials 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/in-depth-profiling-of-mild-psoriasis-patients-paves-the-way-for-future-trials/5e9d4916bd-1746023936/derma-toolbox.jpg https://annualreport.chdr.nl/en/2023/developing-methods/dopamine-novelty-and-motivation-an-academic-collaboration 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/dopamine-novelty-and-motivation-an-academic-collaboration/3925595a89-1746023943/ar2023_fsw_001.jpg https://annualreport.chdr.nl/en/2023/developing-methods/deep-phenotyping-is-core-aim-of-national-immunodermatology-consortium 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/deep-phenotyping-is-core-aim-of-national-immunodermatology-consortium/22f8fe0ce7-1746023934/derma-flower-4-right.png https://annualreport.chdr.nl/en/2023/developing-people 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/en/2023/developing-people/dr-maurits-vissers-new-clinical-operations-director 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/dr-maurits-vissers-new-clinical-operations-director/c4e7b5e360-1746023944/ar2023_maurits_001.jpg https://annualreport.chdr.nl/en/2023/developing-people/cutting-the-red-tape-for-clinical-pharmacology-internships 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/cutting-the-red-tape-for-clinical-pharmacology-internships/c1ede08a5d-1746023944/ar2023_jeroen_002_2048.jpg https://annualreport.chdr.nl/en/2023/developing-people/noor-lansbergen-went-from-administration-to-clinical-programming-i-am-very-happy-with-this-career-switch 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/noor-lansbergen-went-from-administration-to-clinical-programming-i-am-very-happy-with-this-career-switch/0043466792-1746023947/ar2023_noor_001.jpg https://annualreport.chdr.nl/en/2023/developing-people/tailored-education-for-chdr-clinical-scientists 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/tailored-education-for-chdr-clinical-scientists/ea9b663719-1746023946/ar2018_misc_0046-preview.jpg https://annualreport.chdr.nl/en/2023/developing-people/learning-new-things-and-team-building-in-barcelona 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/learning-new-things-and-team-building-in-barcelona/fa9d6a5a7f-1746023947/life-support-training.jpg https://annualreport.chdr.nl/en/2023/developing-people/eight-new-phd-graduates-in-2023 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/eight-new-phd-graduates-in-2023/81f290a2cb-1746023945/leiden-132_2.jpg https://annualreport.chdr.nl/en/2023/jonas-matthias-den-heijer 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/en/2023/stories 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/en/2023/stories/dr-naomi-klarenbeek-appointed-research-director-internal-medicine 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/dr-naomi-klarenbeek-appointed-research-director-internal-medicine/439742a90b-1746023927/ar2023_naomi_001.jpg https://annualreport.chdr.nl/en/2023/stories/new-experimental-medicine-group-looks-at-excitability-in-brain-muscle-and-peripheral-nerve 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-experimental-medicine-group-looks-at-excitability-in-brain-muscle-and-peripheral-nerve/87bee06870-1746023929/ar2023_jules_002.jpg https://annualreport.chdr.nl/en/2023/stories/chdr-opened-special-clinical-research-unit-within-the-lumc 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/chdr-opened-special-clinical-research-unit-within-the-lumc/18f0657cf7-1746023928/chdr-9909.jpg https://annualreport.chdr.nl/en/2023/stories/new-hr-director-christine-van-andel-warm-welcome-in-a-thriving-organisation 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-hr-director-christine-van-andel-warm-welcome-in-a-thriving-organisation/8dbac93f14-1746023925/ar2023_christine_001.jpg https://annualreport.chdr.nl/en/2023/stories/multi-resource-planning-and-recruitment-funnel-improved-operational-efficiency 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/multi-resource-planning-and-recruitment-funnel-improved-operational-efficiency/c5621bc4b0-1746023931/ar2023_planning_002.jpg https://annualreport.chdr.nl/en/2023/stories/campaign-aims-to-improve-the-image-of-clinical-drug-research 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/campaign-aims-to-improve-the-image-of-clinical-drug-research/526c8086a3-1746023924/ar2023_herbert_001.jpg https://annualreport.chdr.nl/en/2023/stories/building-a-new-concept-for-early-oncology-drug-development 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/building-a-new-concept-for-early-oncology-drug-development/d4d0e7b2b0-1746023930/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2023/stories/building-a-new-concept-for-early-oncology-drug-development/39ff8e8e9d-1746023930/lumc-unit-2.png https://annualreport.chdr.nl/en/2023/stories/pandemic-proof-initiative-for-infection-research 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/pandemic-proof-initiative-for-infection-research/cfad2a738a-1746023932/ar2020_preview_070__mg_8354-2.jpg https://annualreport.chdr.nl/en/2023/stories/new-collaborations-for-biomarker-engineering-and-analytics-group 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-collaborations-for-biomarker-engineering-and-analytics-group/9e1c3580aa-1746023933/ar2023_pharmacometrics_001.jpg https://annualreport.chdr.nl/en/2023/stories/working-group-devised-recommendations-for-an-organisation-with-a-unique-culture 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/working-group-devised-recommendations-for-an-organisation-with-a-unique-culture/fecbe5f5f9-1746023927/image-1.jpg https://annualreport.chdr.nl/en/2023/scientific-output 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2023/scientific-output/our-publications-in-2023 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/media/pages/2023/scientific-output/our-publications-in-2023/29a605c279-1746023959/ar-publicaties-2023.jpg https://annualreport.chdr.nl/en/2023/bertine-huisman 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2023/lisa-pagan 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2023/maurits-vissers 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/samantha-prins 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/victor-baart 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/wieke-grievink 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/johan-van-der-plas 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2023/willem-birkhoff 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/en/2022 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/developing-methods 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/developing-methods/deep-phenotyping-mycosis-fungoides-profiling-an-orphan-malignancy 2026-02-18T14:26:22+01:00 https://annualreport.chdr.nl/en/2022/developing-methods/developing-biomarkers-to-study-drugs-for-neurodegenerative-diseases 2026-02-18T14:36:40+01:00 https://annualreport.chdr.nl/en/2022/developing-methods/laying-the-foundations-for-faster-vaccine-development 2026-02-18T15:01:19+01:00 https://annualreport.chdr.nl/en/2022/developing-methods/the-search-for-human-complement-challenge-models 2026-02-18T15:06:13+01:00 https://annualreport.chdr.nl/en/2022/developing-methods/assessing-the-pharmacokinetics-of-large-molecules-in-the-cns 2026-02-18T15:10:31+01:00 https://annualreport.chdr.nl/en/2022/developing-methods/bone-marrow-aspiration-biopsy-and-laboratory-analysis 2026-02-18T15:15:16+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-methods/bone-marrow-aspiration-biopsy-and-laboratory-analysis/0fcade096d-1746023972/ar2022_014.jpg https://annualreport.chdr.nl/en/2022/developing-methods/developing-and-validating-a-finger-tapping-test-for-parkinson-s-disease 2026-02-18T15:34:01+01:00 https://annualreport.chdr.nl/en/2022/developing-people 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/developing-people/leaders-in-pharmacology-education-from-primary-school-to-professional-training 2026-02-18T16:22:27+01:00 https://annualreport.chdr.nl/en/2022/developing-people/collaborating-to-grow-the-human-resources-potential-of-the-leiden-bio-science-park 2026-02-18T16:26:03+01:00 https://annualreport.chdr.nl/en/2022/developing-people/prof-geert-jan-groeneveld-the-revolution-in-neuropharmacology-is-underway 2026-02-18T16:32:46+01:00 https://annualreport.chdr.nl/en/2022/developing-people/on-the-right-path-career-development-at-chdr 2026-02-18T16:34:30+01:00 https://annualreport.chdr.nl/en/2022/developing-people/prof-robert-rissmann-the-golden-hour-of-dermatology-is-just-beginning 2026-02-18T16:35:40+01:00 https://annualreport.chdr.nl/en/2022/developing-people/five-new-phd-graduates-in-2022 2026-02-18T16:37:05+01:00 https://annualreport.chdr.nl/en/2022/2022-in-perspective 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/2022-in-perspective/message-from-the-executive-board 2026-02-18T13:16:46+01:00 https://annualreport.chdr.nl/en/2022/2022-in-perspective/2022-in-numbers 2026-02-18T13:21:32+01:00 https://annualreport.chdr.nl/en/2022/developing-drugs 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/developing-drugs/profiling-novel-gaba-agonists 2026-02-18T14:10:46+01:00 https://annualreport.chdr.nl/en/2022/developing-drugs/sponsor-interview-dr-beate-rohde-bayer 2026-02-18T13:32:14+01:00 https://annualreport.chdr.nl/en/2022/developing-drugs/patients-and-healthy-volunteers-in-an-integrative-approach-to-drug-development-in-oncology 2026-02-18T13:38:33+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-drugs/patients-and-healthy-volunteers-in-an-integrative-approach-to-drug-development-in-oncology/1441fccd41-1746023970/ar2022_003_cropped.jpg https://annualreport.chdr.nl/en/2022/developing-drugs/it-s-been-a-fantastic-journey-dr-thomas-holm-pedersen-nmd-pharma 2026-02-18T13:44:21+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-drugs/it-s-been-a-fantastic-journey-dr-thomas-holm-pedersen-nmd-pharma/76689f8805-1746023969/nmd_pharma_thomas_holm_pedersen_small.jpg https://annualreport.chdr.nl/en/2022/developing-drugs/unlocking-the-potential-of-psychedelic-compounds-in-psychiatry 2026-02-18T14:04:00+01:00 https://annualreport.chdr.nl/en/2022/developing-drugs/sponsor-interview-dr-rachel-gurrell-noema-pharma 2026-02-18T14:10:31+01:00 https://annualreport.chdr.nl/en/2022/developing-drugs/chdr-is-an-active-and-innovative-research-partner-peter-van-der-ark-janssen 2026-02-18T14:23:43+01:00 https://annualreport.chdr.nl/en/2022/https-chdr-nl-library-genetic-and-clinical-pharmacology-studies-in-gba1-associated-parkinson-s-disease-download 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/2022-stories 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/2022-stories/35-years-of-creating-value-in-an-unpredictable-world 2026-02-18T16:40:16+01:00 https://annualreport.chdr.nl/en/2022/2022-stories/fully-prepared-for-the-european-clinical-trials-regulation 2026-02-18T16:41:21+01:00 https://annualreport.chdr.nl/en/2022/2022-stories/new-compensation-guidelines-improve-study-recruitment 2026-02-18T16:55:12+01:00 https://annualreport.chdr.nl/en/2022/2022-stories/prestigious-grant-awarded-to-national-immunodermatology-consortium 2026-02-18T16:58:10+01:00 https://annualreport.chdr.nl/en/2022/2022-stories/1-000th-patient-with-atopic-dermatitis-recruited 2026-02-18T17:02:09+01:00 https://annualreport.chdr.nl/en/2022/publications 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/publications/our-publications-in-2022 2026-02-18T17:03:21+01:00 https://annualreport.chdr.nl/en/2022/thesis-hein-van-der-wall 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/thesis-josine-vrouwe 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/thesis-matthijs-kruizinga 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/en/2022/thesis-hemme-hijma 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/overview 2026-02-05T11:22:49+01:00 https://annualreport.chdr.nl/de/2025 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/de/2025/2025-in-perspective 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/2025-in-perspective/annual-report-2025-where-innovation-meets-application 2026-02-05T10:12:39+01:00 https://annualreport.chdr.nl/de/2025/2025-in-perspective/investing-in-future-success 2026-02-05T09:46:33+01:00 https://annualreport.chdr.nl/de/2025/2025-in-perspective/2025-in-numbers 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/2025-in-perspective/2025-in-numbers/e66dd9baa3-1767706170/ar2024clinical_17_2048.jpg https://annualreport.chdr.nl/de/2025/bas-van-kraaij 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/titia-ruijs 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/gert-jan-hassing 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/eva-thijssen 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/ahnjili-zhuparris 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/jannik-rousel 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/eveline-in-t-veld 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/mahdi-saghari 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/wouter-ten-voorde 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/de/2025/developing-drugs 2026-02-03T16:55:23+01:00 https://annualreport.chdr.nl/de/2025/developing-drugs/neurokit-test-used-in-the-united-kingdom 2026-02-05T09:51:35+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/neurokit-test-used-in-the-united-kingdom/a7a3377772-1770132144/ar2024clinical_13.jpg https://annualreport.chdr.nl/de/2025/developing-drugs/reproducible-results-thanks-to-objective-measurements-dr-gerard-marek-gilgamesh-pharma 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/reproducible-results-thanks-to-objective-measurements-dr-gerard-marek-gilgamesh-pharma/bf12258d82-1770046968/generated-image.png https://annualreport.chdr.nl/de/2025/developing-drugs/complex-study-provided-insight-into-immunological-pathways 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/de/2025/developing-drugs/the-next-step-in-an-immunological-journey-of-discovery-professor-frederic-triebel-immutep 2026-02-03T16:17:19+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/the-next-step-in-an-immunological-journey-of-discovery-professor-frederic-triebel-immutep/4a7ade0b7d-1770029062/triebel.jpg https://annualreport.chdr.nl/de/2025/developing-drugs/favourable-results-for-ampa-pam-osavampator 2026-02-03T16:21:36+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/favourable-results-for-ampa-pam-osavampator/bfac35dbcd-1770132094/chdr-rc-253031.jpg https://annualreport.chdr.nl/de/2025/developing-drugs/novel-treatments-for-patients-with-atopic-dermatitis 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-treatments-for-patients-with-atopic-dermatitis/718a34f7b8-1770028629/chatgpt-image-feb-2-2026-11_36_46-am.png https://annualreport.chdr.nl/de/2025/developing-drugs/promising-results-from-a-novel-psychedelic-compound 2026-02-03T16:22:06+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/promising-results-from-a-novel-psychedelic-compound/44ac96df51-1770132125/ar2024clinical_02.jpg https://annualreport.chdr.nl/de/2025/developing-drugs/new-co2-challenge-setup-ready-for-proof-of-mechanism-studies-with-anxiolytic-drugs 2026-02-03T14:09:26+01:00 https://annualreport.chdr.nl/de/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients 2026-02-03T16:15:20+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients/80df40d53c-1770028865/chatgpt-image-feb-2-2026-11_40_31-am.png https://annualreport.chdr.nl/media/pages/2025/developing-drugs/novel-therapy-for-rheumatoid-arthritis-studied-in-healthy-participants-and-in-patients/7328edb453-1770131719/ra-patient.jpg https://annualreport.chdr.nl/de/2025/developing-drugs/successful-next-step-for-potential-treatment-of-frontotemporal-dementia 2026-02-03T16:26:04+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/successful-next-step-for-potential-treatment-of-frontotemporal-dementia/dbc02f7017-1770132362/chdr-rc-252444.jpg https://annualreport.chdr.nl/de/2025/developing-drugs/genotyped-cohort-facilitates-recruitment-for-studies-in-parkinson-s-disease 2026-02-05T09:35:23+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-drugs/genotyped-cohort-facilitates-recruitment-for-studies-in-parkinson-s-disease/5e2b29d4ab-1770280518/parkinson-swab-studie.jpg https://annualreport.chdr.nl/de/2025/developing-methods 2026-02-03T14:09:27+01:00 https://annualreport.chdr.nl/de/2025/developing-methods/neurokit-ready-for-clinical-studies-in-the-usa 2026-02-05T09:52:37+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/neurokit-ready-for-clinical-studies-in-the-usa/763d2e0bf5-1770133178/neurokit-usa.jpg https://annualreport.chdr.nl/de/2025/developing-methods/utility-function-ranks-opioids 2026-02-03T16:40:14+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/utility-function-ranks-opioids/94b1fec884-1770133213/chdr-rc-252569.jpg https://annualreport.chdr.nl/de/2025/developing-methods/in-depth-insight-into-immunological-challenge-models-allows-for-tailor-made-approach 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/in-depth-insight-into-immunological-challenge-models-allows-for-tailor-made-approach/9917e24c6a-1770029497/chdr-rc-252103.jpg https://annualreport.chdr.nl/de/2025/developing-methods/virtual-reality-as-a-tool-to-map-the-emotional-side-of-pain 2026-02-03T16:42:41+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/virtual-reality-as-a-tool-to-map-the-emotional-side-of-pain/77771599da-1770133359/vr-paincart.jpg https://annualreport.chdr.nl/de/2025/developing-methods/ongoing-innovations-in-recording-electrical-brain-activity 2026-02-05T09:55:38+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/ongoing-innovations-in-recording-electrical-brain-activity/0bf87cf342-1770133235/chdr-rc-251603.jpg https://annualreport.chdr.nl/de/2025/developing-methods/successful-development-of-viral-infection-models 2026-02-05T10:01:35+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/successful-development-of-viral-infection-models/604b3cdcee-1770133394/ar2020_preview_070__mg_8354-1.jpg https://annualreport.chdr.nl/de/2025/developing-methods/oncology-group-builds-on-immunological-challenge-models 2026-02-05T16:21:34+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/oncology-group-builds-on-immunological-challenge-models/f9082e8754-1770133335/2018_derma_0112_preview.jpg https://annualreport.chdr.nl/de/2025/developing-methods/valuable-conclusions-from-existing-eeg-data 2026-02-03T16:39:21+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/valuable-conclusions-from-existing-eeg-data/79eb9a2462-1770133160/ar2024clinical_07.jpg https://annualreport.chdr.nl/de/2025/developing-methods/laying-the-foundation-for-a-new-approach-to-metabolic-studies 2026-02-05T10:18:13+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/laying-the-foundation-for-a-new-approach-to-metabolic-studies/acb70110d5-1770035517/wouter-keuris-fotografie-100-2.jpg https://annualreport.chdr.nl/de/2025/developing-methods/high-frequency-stimulation-a-novel-model-for-chronic-pain 2026-02-03T14:09:27+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/high-frequency-stimulation-a-novel-model-for-chronic-pain/ebd6ed431e-1770029695/chdr-rc-253170.jpg https://annualreport.chdr.nl/de/2025/developing-methods/bringing-one-of-the-most-informative-cns-testing-technologies-to-the-usa-dr-william-martin-ceo-lotus-clinical-research 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/bringing-one-of-the-most-informative-cns-testing-technologies-to-the-usa-dr-william-martin-ceo-lotus-clinical-research/9656d786a3-1770035326/bill-martin.jpg https://annualreport.chdr.nl/de/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology 2026-02-05T10:20:49+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology/e7e9de8070-1770036240/uvb-burn.png https://annualreport.chdr.nl/media/pages/2025/developing-methods/uvb-pain-model-explored-as-a-novel-tool-in-immunology-and-oncology/0509bf56fe-1770131516/uvb-rug.jpg https://annualreport.chdr.nl/de/2025/developing-methods/first-study-in-twente-focuses-on-measurements-of-excitability-of-the-motor-cortex 2026-02-05T16:17:57+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/first-study-in-twente-focuses-on-measurements-of-excitability-of-the-motor-cortex/ec8246edab-1770133303/chdr250708mdf011.jpg https://annualreport.chdr.nl/de/2025/developing-methods/candidate-biomarkers-for-sustained-dmt-effects 2026-02-05T10:39:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/candidate-biomarkers-for-sustained-dmt-effects/8e2853b93a-1770132838/mri-06-mq.jpg https://annualreport.chdr.nl/de/2025/developing-methods/chikungunya-model-ready-for-testing-vaccines-and-antivirals 2026-02-03T16:41:26+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-methods/chikungunya-model-ready-for-testing-vaccines-and-antivirals/b9dce5bac0-1770133285/chdr-rc-252563.jpg https://annualreport.chdr.nl/de/2025/developing-people 2026-02-03T16:53:48+01:00 https://annualreport.chdr.nl/de/2025/developing-people/seven-new-phd-graduates-in-2025 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/developing-people/seven-new-phd-graduates-in-2025/88c881c49e-1767706170/e1634945-1801-4a1b-99df-ae49b62b96fd.jpg https://annualreport.chdr.nl/media/pages/2025/developing-people/seven-new-phd-graduates-in-2025/bcc4289f10-1767706170/leiden-132_2.jpg https://annualreport.chdr.nl/de/2025/developing-people/clinical-pharmacology-trainees-develop-teaching-modules 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/developing-people/chdr-academy-firmly-embedded-in-the-organisation 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/developing-people/i-like-to-identify-the-root-of-a-problem-and-solve-it-together-with-others 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/developing-people/feeling-at-home-in-a-growing-organisation 2026-02-05T10:45:28+01:00 https://annualreport.chdr.nl/de/2025/stories 2026-02-03T16:55:44+01:00 https://annualreport.chdr.nl/de/2025/stories/operations-making-innovations-work 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/operations-making-innovations-work/80680eaf3d-1770034273/chdr-rc-252709.jpg https://annualreport.chdr.nl/de/2025/stories/new-gcp-guideline-based-on-a-fit-for-purpose-perspective 2026-02-05T10:49:24+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/new-gcp-guideline-based-on-a-fit-for-purpose-perspective/de1c3e33b5-1770284963/chdr-rc-252267.jpg https://annualreport.chdr.nl/de/2025/stories/roll-out-of-chdr-deep-phenotyping-approach-in-consortium-study 2026-02-05T10:47:23+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/roll-out-of-chdr-deep-phenotyping-approach-in-consortium-study/291c688f4e-1770284826/preview-0020-derma-lowres.jpg https://annualreport.chdr.nl/de/2025/stories/igor-radanovic-heads-chdr-s-oncology-initiative 2026-02-05T16:19:41+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/igor-radanovic-heads-chdr-s-oncology-initiative/e0cf07edd6-1770285170/chdr-rc-254038.jpg https://annualreport.chdr.nl/de/2025/stories/chdr-twente-pioneering-at-a-new-location 2026-02-05T11:16:34+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/chdr-twente-pioneering-at-a-new-location/3729b3232b-1770285240/chdr251010mdf049v2-1.jpg https://annualreport.chdr.nl/de/2025/stories/clusters-strengthen-internal-synergy 2026-02-10T16:26:47+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/clusters-strengthen-internal-synergy/e8c0d35bde-1770285203/untitled-design-4.jpg https://annualreport.chdr.nl/de/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven 2026-02-11T15:02:33+01:00 https://annualreport.chdr.nl/media/pages/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven/cfd46e7c29-1770285291/afscheid-joop.jpg https://annualreport.chdr.nl/media/pages/2025/stories/symposium-on-biomarker-driven-cns-drug-development-in-honour-of-prof-joop-van-gerven/73f3557571-1770285269/afscheid-joop.webp https://annualreport.chdr.nl/de/2025/scientific-output 2026-02-03T16:56:06+01:00 https://annualreport.chdr.nl/de/2025/scientific-output/our-publications-in-2025 2026-02-10T17:32:26+01:00 https://annualreport.chdr.nl/media/pages/2025/scientific-output/our-publications-in-2025/3e80c66f8f-1767706170/ar-publicaties-2023.jpg https://annualreport.chdr.nl/de/2025/lost-in-translation-the-toll-like-receptor-7-induced-pharmacological-challenge-model-of-the-skin 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/ruben-meijer 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/titiaan-post 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/francis-dijkstra 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/ruben-houvast 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/ingrid-koopmans 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2025/laurence-moss 2026-02-03T14:09:28+01:00 https://annualreport.chdr.nl/de/2024 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/de/2024/bas-van-kraaij 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/titia-ruijs 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/gert-jan-hassing 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/eva-thijssen 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/ahnjili-zhuparris 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/jannik-rousel 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/eveline-in-t-veld 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/mahdi-saghari 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/wouter-ten-voorde 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/2024-in-perspective 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/de/2024/2024-in-perspective/annual-report-2024-from-insights-to-impact 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/de/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years 2026-02-03T14:09:29+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years/1c133d0acd-1746023893/ar2024_21_anouk-geert-2.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/new-board-of-directors-we-are-confident-chdr-will-continue-to-grow-in-the-coming-years/95605ce0b5-1746023892/ar2024_21_anouk-geert.jpg https://annualreport.chdr.nl/de/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030 2026-02-03T14:09:31+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/ecd229be06-1746023897/annual-report-2015-0005-building-highres-1.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/9cffeba6ce-1746023895/jhml1306-7133.jpg https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/chdr-s-strategy-for-2025-2030/52f05871c7-1746023894/screenshot-of-building.png https://annualreport.chdr.nl/de/2024/2024-in-perspective/2024-in-numbers 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/2024-in-perspective/2024-in-numbers/faa535d18b-1746023891/ar2024clinical_17_2048.jpg https://annualreport.chdr.nl/de/2024/developing-drugs 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/de/2024/developing-drugs/using-tms-and-eeg-to-study-a-novel-class-of-drug 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/using-tms-and-eeg-to-study-a-novel-class-of-drug/54cdeeebd4-1746023884/ar2018_methods_0049_tms-eeg-preview.jpg https://annualreport.chdr.nl/de/2024/developing-drugs/towards-a-novel-class-of-painkillers 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/towards-a-novel-class-of-painkillers/68b1dfd1e9-1746023885/clinical-unit-ro160923-590.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/towards-a-novel-class-of-painkillers/62ebf71c34-1746023885/clinical-unit-ro160923-603-1.jpg https://annualreport.chdr.nl/de/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/ed9638c29a-1746023888/ar2024_philip-kremer_02_e1a6445_2048.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/d7f93018b7-1746023888/clinical-unit-ro160923-827.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-new-focus-on-the-central-cholinergic-system/d32af9aabb-1746023888/khansen-03_2048.jpg https://annualreport.chdr.nl/de/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain/998b5bebb0-1746023886/chdr-9v2-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/clinical-study-explores-the-effects-of-cannabis-on-chronic-pain/d80b602bfa-1746023886/clinical-unit.png https://annualreport.chdr.nl/de/2024/developing-drugs/pharmacological-surprises-with-a-well-known-psychedelic-compound 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/pharmacological-surprises-with-a-well-known-psychedelic-compound/10559c1241-1746023883/ar2024_18_gabriel-jacobs.jpg https://annualreport.chdr.nl/de/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/0579053424-1746023890/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/b8845bbf1e-1746023889/chdr-8-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/it-was-all-smooth-sailing-dr-mads-kjolby-vesper-bio/e92eb9a992-1746023890/img_7761.jpeg https://annualreport.chdr.nl/de/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease 2026-02-03T14:09:33+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease/3cb8c2434f-1746023881/ar2018_methods_0106_derma-preview.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/successful-recruitment-of-patients-with-celiac-disease/21dc49bab5-1746023883/wouter-keuris-fotografie-098.jpg https://annualreport.chdr.nl/de/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis/dbc399d8ef-1746023881/ar2023_epilepsie_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-drugs/resetting-the-immune-system-in-sle-and-rheumatoid-arthritis/5dc64afd38-1746023880/contrast-vloeistof-0011-preview.jpg https://annualreport.chdr.nl/de/2024/developing-drugs/studying-novel-immunomodulatory-agents 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/studying-novel-immunomodulatory-agents/d6ec7796b6-1746023879/chdr-developing-drugs-b-v3.00_00_02_00.still001.jpg https://annualreport.chdr.nl/de/2024/developing-drugs/a-brilliant-example-of-an-early-proof-of-mechanism 2026-02-03T14:09:32+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-drugs/a-brilliant-example-of-an-early-proof-of-mechanism/33b1d8a70f-1746023888/cru-1.jpg https://annualreport.chdr.nl/de/2024/developing-methods 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/de/2024/developing-methods/pharmacology-as-the-cornerstone-of-a-multidisciplinary-approach-to-psychedelic-therapies 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/de/2024/developing-methods/studies-involving-healthy-study-participants-can-provide-useful-information-in-immuno-oncology 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/studies-involving-healthy-study-participants-can-provide-useful-information-in-immuno-oncology/a1e34d368d-1746023908/ar2024_matthijs-moerland_02_e1a5964_2048.jpg https://annualreport.chdr.nl/de/2024/developing-methods/expanding-the-applications-for-immunological-challenge-models 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/expanding-the-applications-for-immunological-challenge-models/e86c34dd49-1746023907/2018_derma_0112_preview.jpg https://annualreport.chdr.nl/de/2024/developing-methods/biomarkers-for-neurodegenerative-diseases 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/biomarkers-for-neurodegenerative-diseases/8e4085dccb-1746023909/ar2024_philip-kremer_03_e1a6427_2048_select.jpg https://annualreport.chdr.nl/de/2024/developing-methods/machine-learning-to-unlock-insights-from-deep-phenotyping-data 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/machine-learning-to-unlock-insights-from-deep-phenotyping-data/93b48c1026-1746023898/2018_derma_0115_preview.jpg https://annualreport.chdr.nl/de/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/99df82596a-1746023903/ar2023_jannis_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/8f9a3be304-1746023903/ar2024_19_vasileios-exadaktylos.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/neurokit-developing-a-portable-version-of-the-neurocart/ff3673637f-1746023903/ar2024clinical_08.jpg https://annualreport.chdr.nl/de/2024/developing-methods/trial-home-promising-results-in-clinical-practice 2026-02-03T14:09:35+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/9d2baa8fc8-1746023902/annual-report-2015-0020-clinical-unit-hd-1.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/f016960980-1746023901/annual-report-2015-0020-clinical-unit-highres.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/trial-home-promising-results-in-clinical-practice/3c167d450e-1746023902/in-dept-eeg-analysis.png https://annualreport.chdr.nl/de/2024/developing-methods/viral-infection-model-successfully-implemented 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/viral-infection-model-successfully-implemented/000191e7bc-1746023906/buisje.jpg https://annualreport.chdr.nl/de/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya/c95c3e8575-1746023899/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-methods/controlled-human-infection-models-for-influenza-and-chikungungya/d7c8d955cb-1746023900/in-neus_01_00_00_04.jpg https://annualreport.chdr.nl/de/2024/developing-methods/developing-and-validating-biomarkers-for-chronic-pain 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/developing-and-validating-biomarkers-for-chronic-pain/519a7980f8-1746023904/preview-0056-pain-lowres.jpg https://annualreport.chdr.nl/de/2024/developing-methods/chdr-develops-measurements-for-fatty-liver-disease-and-weight-reduction 2026-02-03T14:09:34+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-methods/chdr-develops-measurements-for-fatty-liver-disease-and-weight-reduction/c85e4a3eb1-1746023905/ar2024_13_naomi-klarenbeek.jpg https://annualreport.chdr.nl/de/2024/developing-people 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/de/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations 2026-02-03T14:09:36+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations/961574345f-1746023914/e1634945-1801-4a1b-99df-ae49b62b96fd.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/record-number-of-phd-s-and-clinical-pharmacologist-graduations/84ab70e5ff-1746023914/leiden-132_2.jpg https://annualreport.chdr.nl/de/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development/2188808fe1-1746023910/ar2023_maurits_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/chdr-academy-education-in-the-service-of-improving-pharmacology-and-drug-development/dcd8d388f7-1746023910/ar2024_09_koos-jeroen.jpg https://annualreport.chdr.nl/de/2024/developing-people/increasing-the-impact-of-the-trc-p-teaching-platform-for-students-and-professionals 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/increasing-the-impact-of-the-trc-p-teaching-platform-for-students-and-professionals/e33a161a8d-1746023913/ar2023_jeroen_002_2048.jpg https://annualreport.chdr.nl/de/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics 2026-02-03T14:09:37+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/8b2f1f5f72-1746023912/ar2023_noor_001.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/64992613e7-1746023912/ar2024_06_linda-aulin-3.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/dr-linda-aulin-team-leader-pharmacometrics/02d4acf9a8-1746023911/ar2024_linda-aulin_06_e1a5092_2048_select.jpg https://annualreport.chdr.nl/de/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/332a8629bf-1746023916/ar2018_misc_0046-preview.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/f25f895c22-1746023916/ar2024_17_doesita-ramkoeber.jpg https://annualreport.chdr.nl/media/pages/2024/developing-people/a-degree-in-management-for-the-clinical-research-unit-team-leaders/4963851572-1746023916/ar2024_doesita-ramkoeber_03_e1a6159_2048.jpg https://annualreport.chdr.nl/de/2024/stories 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/de/2024/stories/collaborating-on-behalf-of-cancer-patients 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/collaborating-on-behalf-of-cancer-patients/2411128ac2-1746023878/ar2024_11_igor-radanovic.jpg https://annualreport.chdr.nl/media/pages/2024/stories/collaborating-on-behalf-of-cancer-patients/8f4b1a340c-1746023879/chdr-9909.jpg https://annualreport.chdr.nl/de/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/51249a3e17-1746023871/ar2023_christine_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/64b3522821-1746023871/ar2024_04_robert-rissman-1.jpg https://annualreport.chdr.nl/media/pages/2024/stories/immunodermatology-consortium-at-the-start-of-a-nationwide-observational-study/e4cfd5b377-1746023870/ar2024_04_robert-rissman.jpg https://annualreport.chdr.nl/de/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium/ce971dbc95-1746023869/ar2023_planning_002.jpg https://annualreport.chdr.nl/media/pages/2024/stories/it-is-important-that-patients-are-involved-in-the-ngid-consortium/856ffaff04-1746023868/p-p.png https://annualreport.chdr.nl/de/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity/a48d3e98bf-1746023873/ar2023_jules_002.jpg https://annualreport.chdr.nl/media/pages/2024/stories/new-chdr-unit-in-the-eastern-netherlands-to-expand-research-capacity/1808656257-1746023873/mst-1408x.jpg https://annualreport.chdr.nl/de/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career 2026-02-03T14:09:39+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career/0715907240-1746023867/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/new-cfo-anouk-de-jong-strategic-thinking-is-the-common-thread-in-my-career/211bd647e1-1746023866/chdr2025-web-anouk-01-v1-1408x.jpg https://annualreport.chdr.nl/de/2024/stories/using-study-participants-feedback-to-improve-recruitment 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/e03180858a-1746023868/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/beafd93a7b-1746023867/branding-chdr.png https://annualreport.chdr.nl/media/pages/2024/stories/using-study-participants-feedback-to-improve-recruitment/8ffaa70d4b-1746023867/lumc-unit-2.png https://annualreport.chdr.nl/de/2024/stories/culture-programme-in-implementation-phase 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/bcc6043a5a-1746023876/ar2024_03_christine-van-andel-1.jpg https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/a974144c60-1746023877/ar2024_03_christine-van-andel.jpg https://annualreport.chdr.nl/media/pages/2024/stories/culture-programme-in-implementation-phase/53105d7018-1746023877/cultuur-programma.png https://annualreport.chdr.nl/de/2024/stories/feedback-driven-hr-strengthening-chdr-s-workforce 2026-02-03T14:09:40+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/feedback-driven-hr-strengthening-chdr-s-workforce/a0e8ecbea7-1746023872/ar2024_03_christine-van-andel-1.jpg https://annualreport.chdr.nl/de/2024/stories/chdr-plays-key-role-in-national-infectious-diseases-facility 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/chdr-plays-key-role-in-national-infectious-diseases-facility/6e59766edf-1746023875/ar2024_16_ingrid.jpg https://annualreport.chdr.nl/de/2024/stories/marieke-niesters-appointed-as-head-of-the-pain-group 2026-02-03T14:09:38+01:00 https://annualreport.chdr.nl/media/pages/2024/stories/marieke-niesters-appointed-as-head-of-the-pain-group/cf95a37ce7-1746023874/ar2024_marieke-niesters_05_e1a4721_2048.jpg https://annualreport.chdr.nl/de/2024/scientific-output 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/de/2024/scientific-output/our-publications-in-2024 2026-02-03T14:09:41+01:00 https://annualreport.chdr.nl/media/pages/2024/scientific-output/our-publications-in-2024/642ec97e4e-1746023897/ar-publicaties-2023.jpg https://annualreport.chdr.nl/de/2023 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/2023-in-perspective 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/2023-in-perspective/bridging-the-gap-to-the-future 2026-02-19T15:13:05+01:00 https://annualreport.chdr.nl/de/2023/2023-in-perspective/2023-in-numbers 2026-02-19T15:16:53+01:00 https://annualreport.chdr.nl/de/2023/developing-drugs 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis 2026-02-19T15:23:30+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis/fcfb25322a-1746023950/lancet-5.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/lancet-publication-novel-malaria-drug-suitable-for-prophylaxis/bf08c91b58-1746023951/lancet-cover.png https://annualreport.chdr.nl/de/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too 2026-02-19T15:29:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too/8980a72621-1746023952/clinical-unit-ro160923-827.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/curiosity-is-one-of-our-company-s-core-values-and-i-m-glad-to-see-it-here-at-chdr-too/35e182fc8a-1746023952/khansen-03_2048.jpg https://annualreport.chdr.nl/de/2023/developing-drugs/the-adventurous-journey-of-an-immunological-compound 2026-02-19T15:38:12+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/the-adventurous-journey-of-an-immunological-compound/21f9600b98-1746023958/ar2023_matthijs_001.jpg https://annualreport.chdr.nl/de/2023/developing-drugs/small-steps-towards-effective-treatments-in-neurodegenerative-disorders 2026-02-19T15:41:08+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/small-steps-towards-effective-treatments-in-neurodegenerative-disorders/a771642a1b-1746023954/ar2023_phillip_001.jpg https://annualreport.chdr.nl/de/2023/developing-drugs/the-spirit-of-the-collaboration-has-been-good 2026-02-19T15:46:41+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/the-spirit-of-the-collaboration-has-been-good/0f8e323970-1746023949/hm-picture-2.png https://annualreport.chdr.nl/de/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis 2026-02-19T15:51:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis/fd2f7f93d6-1746023957/ar2023_naomi_001.jpg https://annualreport.chdr.nl/media/pages/2023/developing-drugs/recruited-patients-with-the-right-degree-of-knee-osteoarthritis/6fece640b4-1746023957/chdr-8-1.jpg https://annualreport.chdr.nl/de/2023/developing-drugs/we-ask-ourselves-what-would-give-us-confidence-to-take-the-next-step-dr-fabienne-schumacher-sanofi 2026-02-19T15:59:25+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/we-ask-ourselves-what-would-give-us-confidence-to-take-the-next-step-dr-fabienne-schumacher-sanofi/086920b23f-1746023956/ar2018_methods_0106_derma-preview.jpg https://annualreport.chdr.nl/de/2023/developing-drugs/sensitivity-to-light-flashes-used-in-antiepileptic-drug-development 2026-02-20T16:09:18+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/sensitivity-to-light-flashes-used-in-antiepileptic-drug-development/612db8d5e1-1746023958/ar2023_epilepsie_001.jpg https://annualreport.chdr.nl/de/2023/developing-drugs/painkiller-aimed-at-promising-target-now-studied-in-phase-iii-trial 2026-02-20T16:18:27+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/painkiller-aimed-at-promising-target-now-studied-in-phase-iii-trial/4357e9a7f2-1746023955/ar2021_mg_1312_preview.jpg https://annualreport.chdr.nl/de/2023/developing-drugs/reducing-respiratory-depression-without-affecting-anaesthesia 2026-02-20T16:23:24+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-drugs/reducing-respiratory-depression-without-affecting-anaesthesia/24b5b6196b-1746023954/cru-1.jpg https://annualreport.chdr.nl/de/2023/developing-methods 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/de/2023/developing-methods/what-can-oncology-research-teach-us-about-drug-development-in-psychiatry 2026-03-10T13:52:52+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/what-can-oncology-research-teach-us-about-drug-development-in-psychiatry/72907f608a-1746023938/ar2023_jannis_001.jpg https://annualreport.chdr.nl/de/2023/developing-methods/extracting-valuable-extra-information-from-the-eeg 2026-03-10T14:00:48+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/extracting-valuable-extra-information-from-the-eeg/cb7e59da9d-1746023938/in-dept-eeg-analysis.png https://annualreport.chdr.nl/de/2023/developing-methods/new-study-design-with-well-known-drug-for-chdr-s-first-integrative-oncology-study 2026-03-10T14:22:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/new-study-design-with-well-known-drug-for-chdr-s-first-integrative-oncology-study/55fe8bb497-1746023935/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/de/2023/developing-methods/deep-phenotyping-patients-to-improve-drug-development 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/deep-phenotyping-patients-to-improve-drug-development/32078431be-1746023939/cru-deep-pheno.jpg https://annualreport.chdr.nl/de/2023/developing-methods/new-tests-to-measure-drug-effects-on-psychological-functioning 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/new-tests-to-measure-drug-effects-on-psychological-functioning/c306e41bf6-1746023942/ar2023_ingrid_001.jpg https://annualreport.chdr.nl/de/2023/developing-methods/cns-profiler-will-facilitate-neurocart-studies-at-other-sites 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/cns-profiler-will-facilitate-neurocart-studies-at-other-sites/f939a43a30-1746023941/ar2023_vr_001.jpg https://annualreport.chdr.nl/de/2023/developing-methods/with-its-expertise-in-excitability-research-the-new-experimental-medicine-group-can-contribute-to-pain-research-and-the-developm 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/with-its-expertise-in-excitability-research-the-new-experimental-medicine-group-can-contribute-to-pain-research-and-the-developm/d59b96256e-1746023936/tms-eeg-2.jpg https://annualreport.chdr.nl/de/2023/developing-methods/rna-sequencing-bridges-preclinical-models-and-clinical-applications 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/rna-sequencing-bridges-preclinical-models-and-clinical-applications/20c55073c3-1746023940/lab-general.jpg https://annualreport.chdr.nl/de/2023/developing-methods/in-depth-profiling-of-mild-psoriasis-patients-paves-the-way-for-future-trials 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/in-depth-profiling-of-mild-psoriasis-patients-paves-the-way-for-future-trials/5e9d4916bd-1746023936/derma-toolbox.jpg https://annualreport.chdr.nl/de/2023/developing-methods/dopamine-novelty-and-motivation-an-academic-collaboration 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/dopamine-novelty-and-motivation-an-academic-collaboration/3925595a89-1746023943/ar2023_fsw_001.jpg https://annualreport.chdr.nl/de/2023/developing-methods/deep-phenotyping-is-core-aim-of-national-immunodermatology-consortium 2026-02-03T14:09:44+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-methods/deep-phenotyping-is-core-aim-of-national-immunodermatology-consortium/22f8fe0ce7-1746023934/derma-flower-4-right.png https://annualreport.chdr.nl/de/2023/developing-people 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/de/2023/developing-people/dr-maurits-vissers-new-clinical-operations-director 2026-02-03T14:09:45+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/dr-maurits-vissers-new-clinical-operations-director/c4e7b5e360-1746023944/ar2023_maurits_001.jpg https://annualreport.chdr.nl/de/2023/developing-people/cutting-the-red-tape-for-clinical-pharmacology-internships 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/cutting-the-red-tape-for-clinical-pharmacology-internships/c1ede08a5d-1746023944/ar2023_jeroen_002_2048.jpg https://annualreport.chdr.nl/de/2023/developing-people/noor-lansbergen-went-from-administration-to-clinical-programming-i-am-very-happy-with-this-career-switch 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/noor-lansbergen-went-from-administration-to-clinical-programming-i-am-very-happy-with-this-career-switch/0043466792-1746023947/ar2023_noor_001.jpg https://annualreport.chdr.nl/de/2023/developing-people/tailored-education-for-chdr-clinical-scientists 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/tailored-education-for-chdr-clinical-scientists/ea9b663719-1746023946/ar2018_misc_0046-preview.jpg https://annualreport.chdr.nl/de/2023/developing-people/learning-new-things-and-team-building-in-barcelona 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/learning-new-things-and-team-building-in-barcelona/fa9d6a5a7f-1746023947/life-support-training.jpg https://annualreport.chdr.nl/de/2023/developing-people/eight-new-phd-graduates-in-2023 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/developing-people/eight-new-phd-graduates-in-2023/81f290a2cb-1746023945/leiden-132_2.jpg https://annualreport.chdr.nl/de/2023/jonas-matthias-den-heijer 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/de/2023/stories 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/de/2023/stories/dr-naomi-klarenbeek-appointed-research-director-internal-medicine 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/dr-naomi-klarenbeek-appointed-research-director-internal-medicine/439742a90b-1746023927/ar2023_naomi_001.jpg https://annualreport.chdr.nl/de/2023/stories/new-experimental-medicine-group-looks-at-excitability-in-brain-muscle-and-peripheral-nerve 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-experimental-medicine-group-looks-at-excitability-in-brain-muscle-and-peripheral-nerve/87bee06870-1746023929/ar2023_jules_002.jpg https://annualreport.chdr.nl/de/2023/stories/chdr-opened-special-clinical-research-unit-within-the-lumc 2026-02-03T14:09:47+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/chdr-opened-special-clinical-research-unit-within-the-lumc/18f0657cf7-1746023928/chdr-9909.jpg https://annualreport.chdr.nl/de/2023/stories/new-hr-director-christine-van-andel-warm-welcome-in-a-thriving-organisation 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-hr-director-christine-van-andel-warm-welcome-in-a-thriving-organisation/8dbac93f14-1746023925/ar2023_christine_001.jpg https://annualreport.chdr.nl/de/2023/stories/multi-resource-planning-and-recruitment-funnel-improved-operational-efficiency 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/multi-resource-planning-and-recruitment-funnel-improved-operational-efficiency/c5621bc4b0-1746023931/ar2023_planning_002.jpg https://annualreport.chdr.nl/de/2023/stories/campaign-aims-to-improve-the-image-of-clinical-drug-research 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/campaign-aims-to-improve-the-image-of-clinical-drug-research/526c8086a3-1746023924/ar2023_herbert_001.jpg https://annualreport.chdr.nl/de/2023/stories/building-a-new-concept-for-early-oncology-drug-development 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/building-a-new-concept-for-early-oncology-drug-development/d4d0e7b2b0-1746023930/ar2023_jacobus_001.jpg https://annualreport.chdr.nl/media/pages/2023/stories/building-a-new-concept-for-early-oncology-drug-development/39ff8e8e9d-1746023930/lumc-unit-2.png https://annualreport.chdr.nl/de/2023/stories/pandemic-proof-initiative-for-infection-research 2026-02-03T14:09:48+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/pandemic-proof-initiative-for-infection-research/cfad2a738a-1746023932/ar2020_preview_070__mg_8354-2.jpg https://annualreport.chdr.nl/de/2023/stories/new-collaborations-for-biomarker-engineering-and-analytics-group 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/new-collaborations-for-biomarker-engineering-and-analytics-group/9e1c3580aa-1746023933/ar2023_pharmacometrics_001.jpg https://annualreport.chdr.nl/de/2023/stories/working-group-devised-recommendations-for-an-organisation-with-a-unique-culture 2026-02-03T14:09:46+01:00 https://annualreport.chdr.nl/media/pages/2023/stories/working-group-devised-recommendations-for-an-organisation-with-a-unique-culture/fecbe5f5f9-1746023927/image-1.jpg https://annualreport.chdr.nl/de/2023/scientific-output 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2023/scientific-output/our-publications-in-2023 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/media/pages/2023/scientific-output/our-publications-in-2023/29a605c279-1746023959/ar-publicaties-2023.jpg https://annualreport.chdr.nl/de/2023/bertine-huisman 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2023/lisa-pagan 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2023/maurits-vissers 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/samantha-prins 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/victor-baart 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/wieke-grievink 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/johan-van-der-plas 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2023/willem-birkhoff 2026-02-03T14:09:42+01:00 https://annualreport.chdr.nl/de/2022 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/developing-methods 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/developing-methods/deep-phenotyping-mycosis-fungoides-profiling-an-orphan-malignancy 2026-02-18T14:26:22+01:00 https://annualreport.chdr.nl/de/2022/developing-methods/developing-biomarkers-to-study-drugs-for-neurodegenerative-diseases 2026-02-18T14:36:40+01:00 https://annualreport.chdr.nl/de/2022/developing-methods/laying-the-foundations-for-faster-vaccine-development 2026-02-18T15:01:19+01:00 https://annualreport.chdr.nl/de/2022/developing-methods/the-search-for-human-complement-challenge-models 2026-02-18T15:06:13+01:00 https://annualreport.chdr.nl/de/2022/developing-methods/assessing-the-pharmacokinetics-of-large-molecules-in-the-cns 2026-02-18T15:10:31+01:00 https://annualreport.chdr.nl/de/2022/developing-methods/bone-marrow-aspiration-biopsy-and-laboratory-analysis 2026-02-18T15:15:16+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-methods/bone-marrow-aspiration-biopsy-and-laboratory-analysis/0fcade096d-1746023972/ar2022_014.jpg https://annualreport.chdr.nl/de/2022/developing-methods/developing-and-validating-a-finger-tapping-test-for-parkinson-s-disease 2026-02-18T15:34:01+01:00 https://annualreport.chdr.nl/de/2022/developing-people 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/developing-people/leaders-in-pharmacology-education-from-primary-school-to-professional-training 2026-02-18T16:22:27+01:00 https://annualreport.chdr.nl/de/2022/developing-people/collaborating-to-grow-the-human-resources-potential-of-the-leiden-bio-science-park 2026-02-18T16:26:03+01:00 https://annualreport.chdr.nl/de/2022/developing-people/prof-geert-jan-groeneveld-the-revolution-in-neuropharmacology-is-underway 2026-02-18T16:32:46+01:00 https://annualreport.chdr.nl/de/2022/developing-people/on-the-right-path-career-development-at-chdr 2026-02-18T16:34:30+01:00 https://annualreport.chdr.nl/de/2022/developing-people/prof-robert-rissmann-the-golden-hour-of-dermatology-is-just-beginning 2026-02-18T16:35:40+01:00 https://annualreport.chdr.nl/de/2022/developing-people/five-new-phd-graduates-in-2022 2026-02-18T16:37:05+01:00 https://annualreport.chdr.nl/de/2022/2022-in-perspective 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/2022-in-perspective/message-from-the-executive-board 2026-02-18T13:16:46+01:00 https://annualreport.chdr.nl/de/2022/2022-in-perspective/2022-in-numbers 2026-02-18T13:21:32+01:00 https://annualreport.chdr.nl/de/2022/developing-drugs 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/developing-drugs/profiling-novel-gaba-agonists 2026-02-18T14:10:46+01:00 https://annualreport.chdr.nl/de/2022/developing-drugs/sponsor-interview-dr-beate-rohde-bayer 2026-02-18T13:32:14+01:00 https://annualreport.chdr.nl/de/2022/developing-drugs/patients-and-healthy-volunteers-in-an-integrative-approach-to-drug-development-in-oncology 2026-02-18T13:38:33+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-drugs/patients-and-healthy-volunteers-in-an-integrative-approach-to-drug-development-in-oncology/1441fccd41-1746023970/ar2022_003_cropped.jpg https://annualreport.chdr.nl/de/2022/developing-drugs/it-s-been-a-fantastic-journey-dr-thomas-holm-pedersen-nmd-pharma 2026-02-18T13:44:21+01:00 https://annualreport.chdr.nl/media/pages/2022/developing-drugs/it-s-been-a-fantastic-journey-dr-thomas-holm-pedersen-nmd-pharma/76689f8805-1746023969/nmd_pharma_thomas_holm_pedersen_small.jpg https://annualreport.chdr.nl/de/2022/developing-drugs/unlocking-the-potential-of-psychedelic-compounds-in-psychiatry 2026-02-18T14:04:00+01:00 https://annualreport.chdr.nl/de/2022/developing-drugs/sponsor-interview-dr-rachel-gurrell-noema-pharma 2026-02-18T14:10:31+01:00 https://annualreport.chdr.nl/de/2022/developing-drugs/chdr-is-an-active-and-innovative-research-partner-peter-van-der-ark-janssen 2026-02-18T14:23:43+01:00 https://annualreport.chdr.nl/de/2022/https-chdr-nl-library-genetic-and-clinical-pharmacology-studies-in-gba1-associated-parkinson-s-disease-download 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/2022-stories 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/2022-stories/35-years-of-creating-value-in-an-unpredictable-world 2026-02-18T16:40:16+01:00 https://annualreport.chdr.nl/de/2022/2022-stories/fully-prepared-for-the-european-clinical-trials-regulation 2026-02-18T16:41:21+01:00 https://annualreport.chdr.nl/de/2022/2022-stories/new-compensation-guidelines-improve-study-recruitment 2026-02-18T16:55:12+01:00 https://annualreport.chdr.nl/de/2022/2022-stories/prestigious-grant-awarded-to-national-immunodermatology-consortium 2026-02-18T16:58:10+01:00 https://annualreport.chdr.nl/de/2022/2022-stories/1-000th-patient-with-atopic-dermatitis-recruited 2026-02-18T17:02:09+01:00 https://annualreport.chdr.nl/de/2022/publications 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/publications/our-publications-in-2022 2026-02-18T17:03:21+01:00 https://annualreport.chdr.nl/de/2022/thesis-hein-van-der-wall 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/thesis-josine-vrouwe 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/thesis-matthijs-kruizinga 2026-02-03T14:09:49+01:00 https://annualreport.chdr.nl/de/2022/thesis-hemme-hijma 2026-02-03T14:09:49+01:00